Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Head and Neck Cancer

  Free Subscription


Articles published in Head Neck

Retrieve available abstracts of 443 articles:
HTML format
Text format



Single Articles


    October 2019
  1. DOOLEY BJ, Karassawa Zanoni D, Mcgill MR, Awad MI, et al
    Intraoperative and postanesthesia care unit fluid administration as risk factors for postoperative complications in patients with head and neck cancer undergoing free tissue transfer.
    Head Neck. 2019 Oct 8. doi: 10.1002/hed.25970.
    PubMed     Text format     Abstract available


  2. PARK H, Harries V, McGill MR, Ganly I, et al
    Isthmusectomy in selected patients with well-differentiated thyroid carcinoma.
    Head Neck. 2019 Oct 7. doi: 10.1002/hed.25968.
    PubMed     Text format     Abstract available


  3. AMINI A, Verma V, Li R, Vora N, et al
    Factors predicting for patient refusal of head and neck cancer therapy.
    Head Neck. 2019 Oct 4. doi: 10.1002/hed.25966.
    PubMed     Text format     Abstract available


  4. KAO HF, Lou PJ
    Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions.
    Head Neck. 2019;41 Suppl 1:4-18.
    PubMed     Text format     Abstract available


  5. LOU PJ
    Preface for the special issue of "Immunotherapy for head and neck cancers: Current landscapes, emerging biomarkers, and future directions".
    Head Neck. 2019;41 Suppl 1:3.
    PubMed     Text format    


  6. CHEN TH, Chang PM, Yang MH
    Novel immune-modulating drugs for advanced head and neck cancer.
    Head Neck. 2019;41 Suppl 1:46-56.
    PubMed     Text format     Abstract available


  7. HSIEH JC, Wang HM, Wu MH, Chang KP, et al
    Review of emerging biomarkers in head and neck squamous cell carcinoma in the era of immunotherapy and targeted therapy.
    Head Neck. 2019;41 Suppl 1:19-45.
    PubMed     Text format     Abstract available


  8. NISHIO N, van Keulen S, van den Berg NS, Lu G, et al
    Probe-based fluorescence dosimetry of an antibody-dye conjugate to identify head and neck cancer as a first step to fluorescence-guided tissue preselection for pathological assessment.
    Head Neck. 2019 Oct 1. doi: 10.1002/hed.25964.
    PubMed     Text format     Abstract available


    September 2019
  9. HAN JE, Yi SK, Wang S, Erman A, et al
    Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease.
    Head Neck. 2019 Sep 14. doi: 10.1002/hed.25955.
    PubMed     Text format     Abstract available


  10. WU L, Zhuo S, Zeng W, Liang S, et al
    Paranasal sinus invasion suggested T4 classification of patients of nasopharyngeal carcinoma: A two-center retrospective investigation.
    Head Neck. 2019 Sep 13. doi: 10.1002/hed.25953.
    PubMed     Text format     Abstract available


  11. RODEN D, Daniels K, Metkus J, Goldman R, et al
    Evaluation of oncologic outcomes in head and neck cancer patients >/=80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment.
    Head Neck. 2019 Sep 12. doi: 10.1002/hed.25950.
    PubMed     Text format     Abstract available


  12. MOWERY AJ, Conlin MJ, Clayburgh DR
    Elevated incidence of head and neck cancer in solid organ transplant recipients.
    Head Neck. 2019 Sep 12. doi: 10.1002/hed.25937.
    PubMed     Text format     Abstract available


  13. GIRKAR F, Thiagarajan S, Malik A, Sawhney S, et al
    Factors predisposing to the development of orocutaneous fistula following surgery for oral cancer: Experience from a tertiary cancer center.
    Head Neck. 2019 Sep 9. doi: 10.1002/hed.25951.
    PubMed     Text format     Abstract available


  14. TAM S, Nurgalieva Z, Weber RS, Lewis CM, et al
    Adherence with National Comprehensive Cancer Network posttreatment surveillance guidelines in patients with head and neck cancer.
    Head Neck. 2019 Sep 9. doi: 10.1002/hed.25936.
    PubMed     Text format     Abstract available


  15. BRISSON RJ, Kochanny S, Arshad S, Dekker A, et al
    A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer.
    Head Neck. 2019 Sep 4. doi: 10.1002/hed.25910.
    PubMed     Text format     Abstract available


    August 2019
  16. KARSTEN RT, Al-Mamgani A, Bril SI, Tjon-A-Joe S, et al
    Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancer.
    Head Neck. 2019 Aug 31. doi: 10.1002/hed.25938.
    PubMed     Text format     Abstract available


  17. XU SY, Yao JJ, Zhou W, Chen L, et al
    Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node-negative papillary thyroid carcinoma without capsule invasion.
    Head Neck. 2019 Aug 29. doi: 10.1002/hed.25941.
    PubMed     Text format     Abstract available


  18. ELDRIDGE RC, Pugh SL, Trotti A, Hu K, et al
    Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study.
    Head Neck. 2019 Aug 22. doi: 10.1002/hed.25922.
    PubMed     Text format     Abstract available


  19. CHEN JH, Huang WY, Ho CL, Chao TY, et al
    Evaluation of oral tegafur-uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non-distant metastatic TNM stage IV nasopharyngeal carcinoma.
    Head Neck. 2019 Aug 22. doi: 10.1002/hed.25904.
    PubMed     Text format     Abstract available


  20. MIMICA X, Hanson M, Patel SG, McGill M, et al
    Salvage surgery for recurrent larynx cancer.
    Head Neck. 2019 Aug 21. doi: 10.1002/hed.25925.
    PubMed     Text format     Abstract available


  21. CHO Y, Yoon HI, Lee IJ, Kim JW, et al
    Patterns of local recurrence after curative resection and reconstruction for oropharyngeal and oral cancers: Implications for postoperative radiotherapy target volumes.
    Head Neck. 2019 Aug 20. doi: 10.1002/hed.25928.
    PubMed     Text format     Abstract available


  22. TAN AL, Iyer NG, Putri N, Nadkarni N, et al
    Factors driving frequent attendance at emergency departments for patients with head and neck cancer.
    Head Neck. 2019 Aug 18. doi: 10.1002/hed.25916.
    PubMed     Text format     Abstract available


  23. SHAH M, Jomaa MK, Ferrarotto R, Yeung SJ, et al
    Serious immune-related adverse events in patients with head and neck cancer after checkpoint blockade: Systematic review.
    Head Neck. 2019 Aug 15. doi: 10.1002/hed.25911.
    PubMed     Text format     Abstract available


  24. GILL AS, Kinzinger M, Bewley AF, Farwell DG, et al
    Malnutrition evaluation in head and neck cancer patients: Practice patterns among otolaryngologists and radiation oncologists.
    Head Neck. 2019 Aug 12. doi: 10.1002/hed.25909.
    PubMed     Text format     Abstract available


  25. LIN DJ, Lam A, Warner L, Paleri V, et al
    Elective neck dissection in patients with radio-recurrent and radio-residual squamous cell carcinoma of the larynx undergoing salvage total laryngectomy: Systematic review and meta-analysis.
    Head Neck. 2019 Aug 10. doi: 10.1002/hed.25907.
    PubMed     Text format     Abstract available


  26. ALMADORI G, De Corso E, Visconti G, Almadori A, et al
    Impact of internal mammary artery perforator propeller flap in neck resurfacing and fistula closure after salvage larynx cancer surgery: Our experience.
    Head Neck. 2019 Aug 9. doi: 10.1002/hed.25903.
    PubMed     Text format     Abstract available


  27. LI H, Li EY, Kejner AE
    Treatment modality and outcomes in larynx cancer patients: A sex-based evaluation.
    Head Neck. 2019 Aug 7. doi: 10.1002/hed.25897.
    PubMed     Text format     Abstract available


  28. MANDAPATHIL M, Lennon P, Ganly I, Patel SG, et al
    Significance and management of incidentally diagnosed metastatic papillary thyroid carcinoma in cervical lymph nodes in neck dissection specimens.
    Head Neck. 2019 Aug 7. doi: 10.1002/hed.25905.
    PubMed     Text format     Abstract available


  29. MASCARELLA MA, Azzi JL, da Silva SD, Mlynarek A, et al
    Postoperative infection predicts poor survival in locoregionally advanced oral cancer.
    Head Neck. 2019 Aug 5. doi: 10.1002/hed.25885.
    PubMed     Text format     Abstract available


  30. MCGURK M
    Surgical consensus guidelines on sentinel node biopsy in patients with oral cancer.
    Head Neck. 2019 Aug 5. doi: 10.1002/hed.25898.
    PubMed     Text format    


  31. KWAN BYM, Khan NM, de Almeida JR, Goldstein D, et al
    Transoral robotic surgery for head and neck malignancies: Imaging features in presurgical workup.
    Head Neck. 2019 Aug 1. doi: 10.1002/hed.25887.
    PubMed     Text format     Abstract available


    July 2019
  32. JAKOB M, Mattes LM, Kuffer S, Unger K, et al
    MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
    Head Neck. 2019 Jul 29. doi: 10.1002/hed.25866.
    PubMed     Text format     Abstract available


  33. ORLANDI E, Bonomo P, Ferella L, D'Angelo E, et al
    Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.
    Head Neck. 2019 Jul 29. doi: 10.1002/hed.25890.
    PubMed     Text format     Abstract available


  34. LE GUEVELOU J, Lebars S, Kammerer E, de Gabory L, et al
    Head and neck cancer during pregnancy.
    Head Neck. 2019 Jul 22. doi: 10.1002/hed.25877.
    PubMed     Text format     Abstract available


  35. MAKITIE AA, Almangush A, Rodrigo JP, Ferlito A, et al
    Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer.
    Head Neck. 2019 Jul 22. doi: 10.1002/hed.25872.
    PubMed     Text format     Abstract available


  36. LU T, Xie X, Guo Q, Zhan S, et al
    Prognosis of nasopharyngeal carcinoma with insufficient radical dose to the primary site in the intensity-modulated radiotherapy era.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25865.
    PubMed     Text format     Abstract available


  37. PAULI N, Mejersjo C, Fagerberg-Mohlin B, Finizia C, et al
    Temporomandibular disorder in head and neck cancer patients undergoing radiotherapy: Clinical findings and patient-reported symptoms.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25878.
    PubMed     Text format     Abstract available


  38. RASSY E, Nicolai P, Pavlidis N
    Comprehensive management of HPV-related squamous cell carcinoma of the head and neck of unknown primary.
    Head Neck. 2019 Jul 13. doi: 10.1002/hed.25858.
    PubMed     Text format     Abstract available


  39. LI X, Zhou J, Chu C, You Q, et al
    Home enteral nutrition may prevent myelosuppression of patients with nasopharyngeal carcinoma treated by concurrent chemoradiotherapy.
    Head Neck. 2019 Jul 12. doi: 10.1002/hed.25861.
    PubMed     Text format     Abstract available


  40. PETRUZZI G, Zocchi J, Moretto S, Pichi B, et al
    Transoral robotic retropharyngeal lymph node dissection in a recurrent head and neck carcinoma.
    Head Neck. 2019 Jul 11. doi: 10.1002/hed.25874.
    PubMed     Text format     Abstract available


  41. ABOUYARED M, Katz AP, Ein L, Ketner J, et al
    Controversies in free tissue transfer for head and neck cancer: A review of the literature.
    Head Neck. 2019 Jul 9. doi: 10.1002/hed.25853.
    PubMed     Text format     Abstract available


  42. KIM SH, Lee WH, Seong D, An JH, et al
    The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation.
    Head Neck. 2019 Jul 3. doi: 10.1002/hed.25868.
    PubMed     Text format     Abstract available


  43. SU Z, Cao X, Zou G
    Brain and frontal-bone metastasis from nasopharyngeal carcinoma: Case report and literature review.
    Head Neck. 2019 Jul 2. doi: 10.1002/hed.25859.
    PubMed     Text format     Abstract available


    June 2019
  44. WANG JR, Nurgalieva Z, Fu S, Tam S, et al
    Utilization of rehabilitation services in patients with head and neck cancer in the United States: A SEER-Medicare analysis.
    Head Neck. 2019 Jun 25. doi: 10.1002/hed.25844.
    PubMed     Text format     Abstract available


  45. MOORE P, Grinsell D, Lyons B, Hewson I, et al
    Outcomes of dental and craniofacial osseointegrated implantation in head and neck cancer patients.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25845.
    PubMed     Text format     Abstract available


  46. WATTERS AL, Cope S, Keller MN, Padilla M, et al
    Prevalence of trismus in patients with head and neck cancer: A systematic review with meta-analysis.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25836.
    PubMed     Text format     Abstract available


  47. OH J, Prisman E, Olson R, Berthelet E, et al
    Primary organ preservation vs total laryngectomy for T4a larynx cancer.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25838.
    PubMed     Text format     Abstract available


  48. HU Y, Lu T, Huang SH, Lin S, et al
    High-grade radiologic extra-nodal extension predicts distant metastasis in stage II nasopharyngeal carcinoma.
    Head Neck. 2019 Jun 17. doi: 10.1002/hed.25842.
    PubMed     Text format     Abstract available


  49. WANG KY, Yang KC, Su FY, Chen YC, et al
    Association between blood pressure and postoperative hematomas in the patients undergoing head and neck cancer reconstruction.
    Head Neck. 2019 Jun 7. doi: 10.1002/hed.25831.
    PubMed     Text format     Abstract available


  50. MIROSEVIC S, Thewes B, van Herpen C, Kaanders J, et al
    Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancer.
    Head Neck. 2019 Jun 7. doi: 10.1002/hed.25812.
    PubMed     Text format     Abstract available


  51. POWROZEK T, Brzozowska A, Mazurek M, Mlak R, et al
    Combined analysis of miRNA-181a with phase angle derived from bioelectrical impedance predicts radiotherapy-induced changes in body composition and survival of male patients with head and neck cancer.
    Head Neck. 2019 Jun 4. doi: 10.1002/hed.25830.
    PubMed     Text format     Abstract available


  52. VUONG HG, Ho ATN, Tran TTK, Capdevila J, et al
    Efficacy and toxicity of sorafenib in the treatment of advanced medullary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2019 Jun 4. doi: 10.1002/hed.25832.
    PubMed     Text format     Abstract available


    May 2019
  53. CHEN JL, Shen CW, Wang CC, Huang YS, et al
    Impact of smoking cessation on clinical outcomes in patients with head and neck squamous cell carcinoma receiving curative chemoradiotherapy: A prospective study.
    Head Neck. 2019 May 22. doi: 10.1002/hed.25814.
    PubMed     Text format     Abstract available


  54. DELAHAUT G, Temam S, Ambroise J, Tao Y, et al
    Prognostic impact of tumor growth velocity in head and neck squamous cell carcinoma treated by radiotherapy: A pilot study.
    Head Neck. 2019 May 14. doi: 10.1002/hed.25789.
    PubMed     Text format     Abstract available


  55. JACOBI C, Gahleitner C, Bier H, Knopf A, et al
    Chemoradiation and local recurrence of head and neck squamous cell carcinoma and the risk of carotid artery blowout.
    Head Neck. 2019 May 9. doi: 10.1002/hed.25796.
    PubMed     Text format     Abstract available


    April 2019
  56. DANIELS KE, Luginbuhl AJ, Mardekian SK, Cognetti DM, et al
    Assessment of quality and consistency of monoclonal antibodies for CB1 and CB2 in head and neck squamous cell carcinoma.
    Head Neck. 2019 Apr 29. doi: 10.1002/hed.25794.
    PubMed     Text format     Abstract available


  57. VAN DE GOOR RMGE, Hardy JCA, van Hooren MRA, Kremer B, et al
    Detecting recurrent head and neck cancer using electronic nose technology: A feasibility study.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25787.
    PubMed     Text format     Abstract available


  58. HO YY, Wu TY, Cheng HC, Yang CC, et al
    The significance of tumor budding in oral cancer survival and its relevance to the eighth edition of the American Joint Committee on Cancer staging system.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25780.
    PubMed     Text format     Abstract available


  59. THAM T, Machado R, Herman SW, Kraus D, et al
    Personalized prognostication in head and neck cancer: A systematic review of nomograms according to the AJCC precision medicine core (PMC) criteria.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25778.
    PubMed     Text format     Abstract available


  60. SONG YC, Hung KF, Liang KL, Chiang JH, et al
    Adjunctive Chinese herbal medicine therapy for nasopharyngeal carcinoma: Clinical evidence and experimental validation.
    Head Neck. 2019 Apr 15. doi: 10.1002/hed.25766.
    PubMed     Text format     Abstract available


  61. DURAN G, Aguin S, Cruz R, Barros F, et al
    Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment.
    Head Neck. 2019 Apr 11. doi: 10.1002/hed.25754.
    PubMed     Text format     Abstract available


  62. DE KORT WWB, Maas SLN, Van Es RJJ, Willems SM, et al
    Prognostic value of the nodal yield in head and neck squamous cell carcinoma: A systematic review.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25764.
    PubMed     Text format     Abstract available


  63. MIYAGAWA Y, Araki K, Yamashita T, Tanaka S, et al
    Induction of cell fusion/apoptosis in anaplastic thyroid carcinoma in orthotopic mouse model by urokinase-specific oncolytic Sendai virus.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25769.
    PubMed     Text format     Abstract available


  64. CHEN F, Yan L, Wang J, Lin L, et al
    Upregulated long noncoding RNA ENST00000470447.1 inhibits cell migration and invasion and predicts better disease-free survival of oral cancer.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25765.
    PubMed     Text format     Abstract available


  65. PANDA S, Thakar A, Sikka K, Sharma SC, et al
    Role of sternomastoid muscle interposition in concomitant transoral oncologic resection and neck dissection.
    Head Neck. 2019 Apr 4. doi: 10.1002/hed.25753.
    PubMed     Text format     Abstract available


    March 2019
  66. YOUNG LK, Vimawala S, Ahmad N, Kushnir V, et al
    Review of inbound medical tourism and legal details of obtaining a visa for treatment of head and neck cancer.
    Head Neck. 2019 Mar 25. doi: 10.1002/hed.25743.
    PubMed     Text format     Abstract available


  67. COSTA EFD, Lopes-Aguiar L, Nogueira GS, Lima TRP, et al
    CASP9 c.-1339A>G and CASP3 c.-1191A>G polymorphisms alter susceptibility and clinical aspects of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 23. doi: 10.1002/hed.25746.
    PubMed     Text format     Abstract available


  68. WANG HM, Wu MH, Chang PH, Lin HC, et al
    The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer.
    Head Neck. 2019 Mar 22. doi: 10.1002/hed.25744.
    PubMed     Text format     Abstract available


  69. MEANS C, Clayburgh DR, Maloney L, Sauer D, et al
    Tumor immune microenvironment characteristics of papillary thyroid carcinoma are associated with histopathological aggressiveness and BRAF mutation status.
    Head Neck. 2019 Mar 21. doi: 10.1002/hed.25740.
    PubMed     Text format     Abstract available


  70. SCHILLING C, Stoeckli SJ, Vigili MG, de Bree R, et al
    Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancer.
    Head Neck. 2019 Mar 21. doi: 10.1002/hed.25739.
    PubMed     Text format     Abstract available


  71. KIM H, Shin JH, Hahn SY, Oh YL, et al
    Prediction of follicular thyroid carcinoma associated with distant metastasis in the preoperative and postoperative model.
    Head Neck. 2019 Mar 19. doi: 10.1002/hed.25721.
    PubMed     Text format     Abstract available


  72. HENRY M, Fuehrmann F, Hier M, Zeitouni A, et al
    Contextual and historical factors for increased levels of anxiety and depression in patients with head and neck cancer: A prospective longitudinal study.
    Head Neck. 2019 Mar 19. doi: 10.1002/hed.25725.
    PubMed     Text format     Abstract available


  73. MORSE RT, Ganju RG, TenNapel MJ, Neupane P, et al
    Weekly cisplatin chemotherapy dosing versus triweekly chemotherapy with concurrent radiation for head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 11. doi: 10.1002/hed.25717.
    PubMed     Text format     Abstract available


  74. JANG JY, Kim DS, Park HY, Shin SC, et al
    Preoperative serum VEGF-C but not VEGF-A level is correlated with lateral neck metastasis in papillary thyroid carcinoma.
    Head Neck. 2019 Mar 7. doi: 10.1002/hed.25729.
    PubMed     Text format     Abstract available


  75. BAI S, Zhang P, Zhang JC, Shen J, et al
    A gene signature associated with prognosis and immune processes in head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 6. doi: 10.1002/hed.25731.
    PubMed     Text format     Abstract available


  76. YASUMATSU R, Wakasaki T, Hashimoto K, Nakashima K, et al
    Monitoring the neutrophil-to-lymphocyte ratio may be useful for predicting the anticancer effect of nivolumab in recurrent or metastatic head and neck cancer.
    Head Neck. 2019 Mar 5. doi: 10.1002/hed.25737.
    PubMed     Text format     Abstract available


  77. MOHAMED A, Twardy B, Zordok MA, Ashraf K, et al
    Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: A comparative analysis.
    Head Neck. 2019 Mar 5. doi: 10.1002/hed.25379.
    PubMed     Text format     Abstract available


  78. NAKANO K, Seto A, Sasaki T, Shimbashi W, et al
    Incidence and risk factors of interstitial lung disease of patients with head and neck cancer treated with cetuximab.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25727.
    PubMed     Text format     Abstract available


  79. FADEN DL, Concha-Benavente F, Chakka AB, McMichael EL, et al
    Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25726.
    PubMed     Text format     Abstract available


  80. VAN SCHAIK JE, Muller Kobold AC, van der Laan BFAM, van der Vegt B, et al
    Squamous cell carcinoma antigen concentration in fine needle aspiration samples: A new method to detect cervical lymph node metastases of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25733.
    PubMed     Text format     Abstract available


  81. MORATIN J, Metzger K, Safaltin A, Herpel E, et al
    Upregulation of PD-L1 and PD-L2 in neck node metastases of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 1. doi: 10.1002/hed.25713.
    PubMed     Text format     Abstract available


    February 2019
  82. TU HF, Chen MY, Lai JC, Chen YL, et al
    Arecoline-regulated ataxia telangiectasia mutated expression level in oral cancer progression.
    Head Neck. 2019 Feb 28. doi: 10.1002/hed.25718.
    PubMed     Text format     Abstract available


  83. MIRZA AH, Thomas G, Ottensmeier CH, King EV, et al
    Importance of the immune system in head and neck cancer.
    Head Neck. 2019 Feb 28. doi: 10.1002/hed.25716.
    PubMed     Text format     Abstract available


  84. KAO LT, Hung SH, Kao PF, Liu JC, et al
    Inverse association between statin use and head and neck cancer: A population-based case-control study in Han population.
    Head Neck. 2019 Feb 26. doi: 10.1002/hed.25501.
    PubMed     Text format     Abstract available


  85. RODRIGUES-JUNIOR DM, Tan SS, Lim SK, de Souza Viana L, et al
    High expression of MLANA in the plasma of patients with head and neck squamous cell carcinoma as a predictor of tumor progression.
    Head Neck. 2019 Feb 25. doi: 10.1002/hed.25510.
    PubMed     Text format     Abstract available


  86. ROBBINS KT, Medina J, Ferlito A
    Adding clarity to the historical evolution of the selective neck dissection.
    Head Neck. 2019 Feb 23. doi: 10.1002/hed.25704.
    PubMed     Text format    


  87. STELZLE F, Oetter N, Goellner LT, Adler W, et al
    Speech intelligibility in patients with oral cancer: An objective baseline evaluation of pretreatment function and impairment.
    Head Neck. 2019 Feb 23. doi: 10.1002/hed.25527.
    PubMed     Text format     Abstract available


  88. SMEE R, Williams JR, Kotevski DP
    Surgery is not the only determinant of an outcome in patients with hypopharyngeal carcinoma.
    Head Neck. 2019 Feb 21. doi: 10.1002/hed.25496.
    PubMed     Text format     Abstract available


  89. BATES JE, De Leo AN, Morris CG, Amdur RJ, et al
    Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes.
    Head Neck. 2019 Feb 20. doi: 10.1002/hed.25695.
    PubMed     Text format     Abstract available


  90. WALD P, Grecula J, Walston S, Wei L, et al
    Intraoperative electron beam radiotherapy for locoregionally persistent or recurrent head and neck cancer.
    Head Neck. 2019 Feb 19. doi: 10.1002/hed.25673.
    PubMed     Text format     Abstract available


  91. TASSLER AB, Gooding WE, Ferris RL
    Hypopharyngeal cancer treatment: Does initial surgery confer survival benefit?
    Head Neck. 2019 Feb 19. doi: 10.1002/hed.25687.
    PubMed     Text format     Abstract available


  92. SHAHA AR
    Recent historic perspective on modified neck dissection.
    Head Neck. 2019 Feb 18. doi: 10.1002/hed.25700.
    PubMed     Text format    


  93. WANG B, Weng YJ, Wang SS, Zhao WX, et al
    Feasibility and safety of needle-assisted endoscopic thyroidectomy with lateral neck dissection for papillary thyroid carcinoma: a preliminary experience.
    Head Neck. 2019 Feb 18. doi: 10.1002/hed.25705.
    PubMed     Text format     Abstract available


  94. KHARIWALA SS, Rubin N, Stepanov I, Nollen N, et al
    "Cold turkey" or pharmacotherapy: Examination of tobacco cessation methods tried among smokers prior to developing head and neck cancer.
    Head Neck. 2019 Feb 15. doi: 10.1002/hed.25708.
    PubMed     Text format     Abstract available


  95. VAN DEN STEEN L, Van Gestel D, Vanderveken O, Vanderwegen J, et al
    Evolution of self-perceived swallowing function, tongue strength and swallow-related quality of life during radiotherapy in head and neck cancer patients.
    Head Neck. 2019 Feb 14. doi: 10.1002/hed.25684.
    PubMed     Text format     Abstract available


  96. KIM HK, Park D, Kim HY
    Robotic transoral thyroidectomy: Total thyroidectomy and ipsilateral central neck dissection with da Vinci Xi Surgical System.
    Head Neck. 2019 Feb 13. doi: 10.1002/hed.25661.
    PubMed     Text format     Abstract available


  97. COCA-PELAZ A, Halmos GB, Strojan P, de Bree R, et al
    The role of age in treatment-related adverse events in patients with head and neck cancer: A systematic review.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25696.
    PubMed     Text format     Abstract available


  98. SUN W, Chen L, Huang JQ, Li J, et al
    Dynamic changes in chemosensitivity immune predictors in patients with hypopharyngeal cancer treated with induction chemotherapy.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25699.
    PubMed     Text format     Abstract available


  99. AVKSHTOL V, Handorf EA, Ridge JA, Leachman BK, et al
    Examining adjuvant radiation dose in head and neck squamous cell carcinoma.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25680.
    PubMed     Text format     Abstract available


  100. LIU J, Lu D, Deng D, Wang J, et al
    Free posterior tibial artery perforator flap for 2-stage tracheal reconstruction in patients after resection of well-differentiated thyroid carcinoma invading the trachea.
    Head Neck. 2019 Feb 6. doi: 10.1002/hed.25675.
    PubMed     Text format     Abstract available


  101. HUTCHISON AR, Cartmill B, Wall LR, Ward EC, et al
    Dysphagia optimized radiotherapy to reduce swallowing dysfunction severity in patients undergoing treatment for head and neck cancer: A systematized scoping review.
    Head Neck. 2019 Feb 5. doi: 10.1002/hed.25688.
    PubMed     Text format     Abstract available


  102. MUELLER SA, Riggauer J, Elicin O, Blaser D, et al
    Patients' preferences concerning follow-up after curative head and neck cancer treatment: A cross-sectional pilot study.
    Head Neck. 2019 Feb 5. doi: 10.1002/hed.25686.
    PubMed     Text format     Abstract available


  103. LI L, Sun Z, Huang X, Li X, et al
    Role of c-Met expression on prognosis of head and neck cancer: A literature review and meta-analysis.
    Head Neck. 2019 Feb 1. doi: 10.1002/hed.25655.
    PubMed     Text format     Abstract available


    January 2019
  104. STRIETH S, Ernst BP, Both I, Hirth D, et al
    Randomized controlled single-blinded clinical trial of functional voice outcome after vascular targeting KTP laser microsurgery of early laryngeal cancer.
    Head Neck. 2019 Jan 31. doi: 10.1002/hed.25474.
    PubMed     Text format     Abstract available


  105. BUSSU F, Tagliaferri L, Mattiucci G, Parrilla C, et al
    HDR interventional radiotherapy (brachytherapy) in the treatment of primary and recurrent head and neck malignancies.
    Head Neck. 2019 Jan 30. doi: 10.1002/hed.25646.
    PubMed     Text format     Abstract available


  106. LANG S, Schimansky S, Beynon R, Penfold C, et al
    Dietary behaviors and survival in people with head and neck cancer: Results from Head and Neck 5000.
    Head Neck. 2019 Jan 30. doi: 10.1002/hed.25660.
    PubMed     Text format     Abstract available


  107. ARBAB M, Margalit DN, Tishler RB, Rabinowits G, et al
    Outcomes following radiation for cutaneous squamous cell carcinoma of the head and neck: Associations between immune suppression and recurrence.
    Head Neck. 2019 Jan 29. doi: 10.1002/hed.25663.
    PubMed     Text format     Abstract available


  108. SWEGAL WC, Iwata AJ, Chang SS
    Developing a patient driven head and neck cancer care pathway.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25590.
    PubMed     Text format    


  109. MENDEZ LC, Conrad T, Lee J, Smith B, et al
    Prospective evaluation of pretreatment and intratreatment FDG PET-CT SUV stability in primary head and neck cancer.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25624.
    PubMed     Text format     Abstract available


  110. DEN TOOM IJ, Janssen LM, van Es RJJ, Karagozoglu KH, et al
    Depth of invasion in patients with early stage oral cancer staged by sentinel node biopsy.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25665.
    PubMed     Text format     Abstract available


  111. RILEY CA, Marino MJ, Hsieh MC, Wu EL, et al
    Detection of laryngeal carcinoma in the U.S. elderly population with gastroesophageal reflux disease.
    Head Neck. 2019 Jan 25. doi: 10.1002/hed.25600.
    PubMed     Text format     Abstract available


  112. KLIGERMAN MP, Sethi RKV, Kozin ED, Gray ST, et al
    Morbidity and mortality among patients with head and neck cancer in the emergency department: A national perspective.
    Head Neck. 2019 Jan 24. doi: 10.1002/hed.25534.
    PubMed     Text format     Abstract available


  113. MENNINI FS, Marcellusi A, Fabiano G, Platini F, et al
    Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer.
    Head Neck. 2019 Jan 24. doi: 10.1002/hed.25481.
    PubMed     Text format     Abstract available


  114. BUTTERWORTH CJ
    Primary vs secondary zygomatic implant placement in patients with head and neck cancer-A 10-year prospective study.
    Head Neck. 2019 Jan 21. doi: 10.1002/hed.25645.
    PubMed     Text format     Abstract available


  115. SOOD A, Wykes J, Roshan D, Wang LY, et al
    A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 19. doi: 10.1002/hed.25599.
    PubMed     Text format     Abstract available


  116. MIRABILE A, Miceli R, Calderone RG, Locati L, et al
    Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25636.
    PubMed     Text format     Abstract available


  117. KRAAIJENGA SA, Hamming-Vrieze O, Verheijen S, Lamers E, et al
    Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25573.
    PubMed     Text format     Abstract available


  118. HUANG HI, Chen CH, Wang SH, Wang LH, et al
    Effects of APE1 Asp148Glu polymorphisms on OPMD malignant transformation, and on susceptibility to and overall survival of oral cancer in Taiwan.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25576.
    PubMed     Text format     Abstract available


  119. FAGAN JJ, Otiti J, Aswani J, Konney A, et al
    African head and neck fellowships: A model for a sustainable impact on head and neck cancer care in developing countries.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25615.
    PubMed     Text format     Abstract available


  120. PAVON MA, Arroyo-Solera I, Leon X, Tellez-Gabriel M, et al
    The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypes.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25623.
    PubMed     Text format     Abstract available


  121. CABEZAS-CAMARERO S, Garcia-Barberan V, Saiz-Pardo Sanz M, Cabrera-Martin MN, et al
    Durable intracranial and extracranial response to nivolumab with appearance of secondary resistance in a heavily pretreated patient with head and neck cancer.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25635.
    PubMed     Text format     Abstract available


  122. SU WW, Su CW, Chang DC, Chuang SL, et al
    Impact of varying anatomic sites on advanced stage and survival of oral cancer: A 9-year prospective cohort of 27 717 cases.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25579.
    PubMed     Text format     Abstract available


  123. BUGTER O, van Iwaarden DLP, Dronkers EAC, de Herdt MJ, et al
    Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25595.
    PubMed     Text format     Abstract available


  124. MEHTA V, Ow TJ, Kim S, Tharakan T, et al
    Significant racial differences in the incidence and behavior of the follicular variant of papillary thyroid carcinoma.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25596.
    PubMed     Text format     Abstract available


  125. SINGER S, Amdal CD, Hammerlid E, Tomaszewska IM, et al
    International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV.
    Head Neck. 2019 Jan 12. doi: 10.1002/hed.25609.
    PubMed     Text format     Abstract available


  126. LEE JW, Ban MJ, Park JH, Lee SM, et al
    Visceral adipose tissue volume and CT-attenuation as prognostic factors in patients with head and neck cancer.
    Head Neck. 2019 Jan 12. doi: 10.1002/hed.25605.
    PubMed     Text format     Abstract available


  127. BECKHAM TH, Leeman J, Jillian Tsai C, Riaz N, et al
    Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: A series of 9 cases and review of the literature.
    Head Neck. 2019 Jan 11. doi: 10.1002/hed.25577.
    PubMed     Text format     Abstract available


  128. CHAN JW, Yeh I, El-Sayed IH, Algazi AP, et al
    Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary site.
    Head Neck. 2019 Jan 11. doi: 10.1002/hed.25613.
    PubMed     Text format     Abstract available


  129. VAN DAELE DJ, Langmore SE, Krisciunas GP, Lazarus CL, et al
    The impact of time after radiation treatment on dysphagia in patients with head and neck cancer enrolled in a swallowing therapy program.
    Head Neck. 2019 Jan 10. doi: 10.1002/hed.25344.
    PubMed     Text format     Abstract available


  130. TESHIMA M, Otsuki N, Shinomiya H, Morita N, et al
    Impact of retropharyngeal lymph node dissection in the surgical treatment of hypopharyngeal cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25608.
    PubMed     Text format     Abstract available


  131. XIANG ZZ, Liu F, Yan RN, Zeng YY, et al
    The prognostic value of volumetric reduction of the target lesions after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25620.
    PubMed     Text format     Abstract available


  132. IWATA AJ, Olden HA, Kippen KE, Swegal WC, et al
    A flexible model for patient engagement: Achieving quality outcomes and building a research agenda for head and neck cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25584.
    PubMed     Text format     Abstract available


  133. WHITE JM, Panchal NH, Wehler CJ, Bestgen SC, et al
    Department of Veterans Affairs Consensus: Preradiation dental treatment guidelines for patients with head and neck cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25519.
    PubMed     Text format     Abstract available


  134. INGARFIELD K, McMahon AD, Douglas CM, Savage SA, et al
    Determinants of long-term survival in a population-based cohort study of patients with head and neck cancer from Scotland.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25630.
    PubMed     Text format     Abstract available


  135. MONTES DE OCA MK, Nye A, Porter C, Collins J, et al
    Head and neck cancer PEG site metastases: Association with PEG placement method.
    Head Neck. 2019 Jan 7. doi: 10.1002/hed.25564.
    PubMed     Text format     Abstract available


  136. DENARO AN, Merlano MC
    Unexpected response with palliative conventional therapy in head and neck squamous cell carcinoma after anti-programmed death-1 progression.
    Head Neck. 2019 Jan 5. doi: 10.1002/hed.25418.
    PubMed     Text format     Abstract available


  137. MAYFIELD JD, Mercado CE, Kaye FJ, Mendenhall WM, et al
    Cetuximab-associated pulmonary toxicity in concurrent chemoradiation for the treatment of a squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 5. doi: 10.1002/hed.25528.
    PubMed     Text format     Abstract available


    December 2018
  138. LIN CS, Chen YW, Liu SC, Tsao CC, et al
    Treatment outcomes with whole-field versus split-field intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Head Neck. 2018 Dec 31. doi: 10.1002/hed.25328.
    PubMed     Text format     Abstract available


  139. GILL A, Givi BB, Moore MG
    AHNS Series - Do you know your guidelines?: Assessment and management of malnutrition in patients with head and neck cancer: A review of the NCCN Clinical Practice Guidelines In Oncology (NCCN Guidelines((R)) ).
    Head Neck. 2018 Dec 31. doi: 10.1002/hed.24866.
    PubMed     Text format     Abstract available


  140. YANG L, Huang Y, Zhou L, Dai Y, et al
    High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 30. doi: 10.1002/hed.25583.
    PubMed     Text format     Abstract available


  141. RAMOS-GARCIA P, Gonzalez-Moles MA, Ayen A, Gonzalez-Ruiz L, et al
    Prognostic and clinicopathological significance of CTTN/cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Head Neck. 2018 Dec 30. doi: 10.1002/hed.25632.
    PubMed     Text format     Abstract available


  142. TIAN YM, Liu MZ, Zeng L, Bai L, et al
    Long-term outcome and pattern of failure for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25545.
    PubMed     Text format     Abstract available


  143. BUGTER O, van de Ven SEM, Hardillo JA, Bruno MJ, et al
    Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25548.
    PubMed     Text format     Abstract available


  144. MIRZA AH, Aylin P, Middleton S, King EV, et al
    Impact of social deprivation on the outcome of major head and neck cancer surgery in England: A national analysis.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25461.
    PubMed     Text format     Abstract available


  145. ALVES-PAIVA RM, Gutierrez-Rodrigues F, Pereira-Martins DA, Figueiredo DLA, et al
    Short telomere length in peripheral blood leukocytes in head and neck cancer: Findings in a Brazilian cohort.
    Head Neck. 2018 Dec 27. doi: 10.1002/hed.25472.
    PubMed     Text format     Abstract available


  146. HOLLOWS R, Wei W, Cazier JB, Mehanna H, et al
    Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25537.
    PubMed     Text format     Abstract available


  147. CAO C, Wei Q, Tang X, Jia Y, et al
    PD-1 and PD-L1 in locoregionally advanced nasopharyngeal carcinoma: A substudy of a randomized phase III trial.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25601.
    PubMed     Text format     Abstract available


  148. TANDON S, Gairola M, Ahlawat P, Karimi AM, et al
    Failure patterns of head and neck squamous cell carcinoma treated with radical radiotherapy by intensity modulated radiotherapy technique using focal volume and dosimetric method.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25586.
    PubMed     Text format     Abstract available


  149. FATTOUH M, Chang GY, Ow TJ, Shifteh K, et al
    Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25420.
    PubMed     Text format     Abstract available


  150. DI MAIO P, Iocca O, De Virgilio A, Ferreli F, et al
    Role of palatine tonsillectomy in the diagnostic workup of head and neck squamous cell carcinoma of unknown primary origin: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 21. doi: 10.1002/hed.25522.
    PubMed     Text format     Abstract available


  151. KWON DI, Miles BA
    Hypopharyngeal carcinoma: Do you know your guidelines?
    Head Neck. 2018 Dec 20. doi: 10.1002/hed.24752.
    PubMed     Text format     Abstract available


  152. VAN DER GEER SJ, van Rijn PV, Kamstra JI, Langendijk JA, et al
    Prevalence and prediction of trismus in patients with head and neck cancer: A cross-sectional study.
    Head Neck. 2018 Dec 18. doi: 10.1002/hed.25369.
    PubMed     Text format     Abstract available


  153. WANG L, Han S, Zhu J, Wang X, et al
    Proton versus photon radiation-induced cell death in head and neck cancer cells.
    Head Neck. 2018 Dec 18. doi: 10.1002/hed.25357.
    PubMed     Text format     Abstract available


  154. KABARRITI R, Baliga S, Ohri N, Guha C, et al
    Radiation therapy for patients with newly diagnosed metastatic head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 16. doi: 10.1002/hed.25476.
    PubMed     Text format     Abstract available


  155. IBRAHIM MY, Nunez MI, Harun N, Lee JJ, et al
    PI3-kinase pathway biomarkers in oral cancer and tumor immune cells.
    Head Neck. 2018 Dec 16. doi: 10.1002/hed.25350.
    PubMed     Text format     Abstract available


  156. WANG K, Moon DH, Amdur RJ, Dagan R, et al
    Shoulder symptoms and quality of life impact of limited neck dissection after de-intensified chemoradiotherapy: Secondary analysis of two prospective trials.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25535.
    PubMed     Text format     Abstract available


  157. EGYUD M, Sridhar P, Devaiah A, Yamada E, et al
    Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25563.
    PubMed     Text format     Abstract available


  158. PLASCHKE CC, Johannesen HH, Hansen RH, Hendel HW, et al
    The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25454.
    PubMed     Text format     Abstract available


  159. SLAVIK M, Shatokhina T, Sana J, Ahmad P, et al
    Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapy.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25533.
    PubMed     Text format     Abstract available


  160. KUBOKI A, Kanaya H, Nakayama T, Konno W, et al
    Prognostic value of C-reactive protein/albumin ratio for patients with hypopharyngeal and laryngeal cancer undergoing invasive surgery involving laryngectomy.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25565.
    PubMed     Text format     Abstract available


  161. LEE YA, Li S, Chen Y, Li Q, et al
    Tobacco smoking, alcohol drinking, betel quid chewing, and the risk of head and neck cancer in an East Asian population.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25383.
    PubMed     Text format     Abstract available


  162. WANG Y, Xie D, Wang Z, Zhang X, et al
    Kinetics of indocyanine green: Optimizing tumor to normal tissue fluorescence in image-guided oral cancer surgery applications.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25541.
    PubMed     Text format     Abstract available


  163. ODENTHAL J, Friedl P, Takes RP
    Compatibility of CO2 laser surgery and fluorescence detection in head and neck cancer cells.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25547.
    PubMed     Text format     Abstract available


  164. KARABULUT B
    AHNS series: Do you know our guidelines? Review of current knowledge on laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25491.
    PubMed     Text format    


  165. PAGEDAR NA, Davis AB, Sperry SM, Charlton ME, et al
    Population analysis of socioeconomic status and otolaryngologist distribution on head and neck cancer outcomes.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25521.
    PubMed     Text format     Abstract available


  166. PAKKANEN PP, Aaltonen LM, Sorsa TA, Tervahartiala TI, et al
    Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25459.
    PubMed     Text format     Abstract available


  167. RUUSKANEN M, Irjala H, Minn H, Vahlberg T, et al
    Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25450.
    PubMed     Text format     Abstract available


  168. ARRESE LC, Schieve HJ, Graham JM, Stephens JA, et al
    Relationship between oral intake, patient perceived swallowing impairment, and objective videofluoroscopic measures of swallowing in patients with head and neck cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25542.
    PubMed     Text format     Abstract available


  169. GUEZENNEC C, Robin P, Orlhac F, Bourhis D, et al
    Prognostic value of textural indices extracted from pretherapeutic 18-F FDG-PET/CT in head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25433.
    PubMed     Text format     Abstract available


  170. SCHIMANSKY S, Lang S, Beynon R, Penfold C, et al
    Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25543.
    PubMed     Text format     Abstract available


  171. ZHU Y, Liu H, Xie N, Liu X, et al
    Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25462.
    PubMed     Text format     Abstract available


  172. TAMAKI A
    HED-17-0417-AHNS series: Do you know your guidelines? A review of current knowledge on laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25448.
    PubMed     Text format    


  173. GAO W, Wong TS, Lv KX, Zhang MJ, et al
    Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25544.
    PubMed     Text format     Abstract available


  174. TUMATI V, Hoang L, Sumer BD, Truelson JM, et al
    Association between treatment delays and oncologic outcome in patients treated with surgery and radiotherapy for head and neck cancer.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25457.
    PubMed     Text format     Abstract available


  175. SHAHID N, Iqbal A, Siddiqui AJ, Shoaib M, et al
    Plasma metabolite profiling and chemometric analyses of tobacco snuff dippers and patients with oral cancer: Relationship between metabolic signatures.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25511.
    PubMed     Text format     Abstract available


  176. RODNER E, Bocklitz T, von Eggeling F, Ernst G, et al
    Fully convolutional networks in multimodal nonlinear microscopy images for automated detection of head and neck carcinoma: A pilot study.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25489.
    PubMed     Text format     Abstract available


  177. KIM TH, Lee IJ, Kim JH, Lee CG, et al
    High-dose versus standard-dose radiation therapy for cervical esophageal cancer: A retrospective single-institution study.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25483.
    PubMed     Text format     Abstract available


  178. QUATRE R, Jacquet T, Atallah I, Tillement O, et al
    Evaluation of the theranostic properties of gadolinium-based nanoparticles for head and neck cancer.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25460.
    PubMed     Text format     Abstract available


  179. PANTVAIDYA G, Sivasanker M, Ranganathan P, Pai P, et al
    Prospective cross-sectional study assessing prevalence and factors affecting trismus after multimodal treatment for oral cancers.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25464.
    PubMed     Text format     Abstract available


  180. LADANYI A, Kapuvari B, Papp E, Toth E, et al
    Local immune parameters as potential predictive markers in head and neck squamous cell carcinoma patients receiving induction chemotherapy and cetuximab.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25546.
    PubMed     Text format     Abstract available


  181. ARROYO-SOLERA I, Pavon MA, Leon X, Lopez M, et al
    Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25437.
    PubMed     Text format     Abstract available


  182. MIYAMARU S, Minoda R, Kodama N
    Long-term changes in vocal function after supracricoid partial laryngectomy with cricohyoidoepiglottopexy for laryngeal cancer.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25487.
    PubMed     Text format     Abstract available


  183. LUMLEY CJ, Kaffenberger TM, Desale S, Tefera E, et al
    Post-diagnosis aspirin use and survival in veterans with head and neck cancer.
    Head Neck. 2018 Dec 11. doi: 10.1002/hed.25518.
    PubMed     Text format     Abstract available


  184. FANG FM, Huang TL, Lin YH, Chien CY, et al
    Concurrent chemoradiotherapy by simultaneously integrated boost volumetric-modulated arc therapy for nasopharyngeal carcinoma-toxicity/quality of life and survival.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25551.
    PubMed     Text format     Abstract available


  185. KUWABARA H, Toriihara A, Yuasa-Nakagawa K, Toda K, et al
    Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25490.
    PubMed     Text format     Abstract available


  186. YANG CY, Lin CK, Hsieh CC, Tsao CH, et al
    Anti-oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient-derived tumor xenograft model.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25554.
    PubMed     Text format     Abstract available


  187. LEE JH, Chun YS, Chung YS
    Extent of lateral neck dissection for papillary thyroid microcarcinomas.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25570.
    PubMed     Text format     Abstract available


  188. RYU HJ, Kim EK, Cho BC, Yoon SO, et al
    Characterization of head and neck squamous cell carcinoma arising in young patients: Particular focus on molecular alteration and tumor immunity.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25507.
    PubMed     Text format     Abstract available


  189. MCSPADDEN R, Zender C, Eskander A
    AHNS series: Do you know your guidelines? Guideline recommendations for recurrent and persistent head and neck cancer after primary treatment.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25443.
    PubMed     Text format     Abstract available


  190. CHOI JB, Lee SG, Kim MJ, Kim TH, et al
    Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25356.
    PubMed     Text format     Abstract available


  191. OKAZAKI E, Kawabe J, Oishi M, Hosono M, et al
    Prognostic significance of pretreatment 18F-fluorodeoxyglucose positron emission tomography evaluation using metabolic tumor volume of the primary tumor and lymph nodes in advanced hypopharyngeal cancer.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25429.
    PubMed     Text format     Abstract available


  192. HUTCHESON KA, Nurgalieva Z, Zhao H, Gunn GB, et al
    Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25412.
    PubMed     Text format     Abstract available


  193. ROTMAN A, Kerr SJ, Giddings CEB
    Elective neck dissection in metastatic cutaneous squamous cell carcinoma to the parotid gland: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25561.
    PubMed     Text format     Abstract available


  194. DRIESSEN CML, Leijendeckers J, Snik A, van der Graaf WTA, et al
    Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25434.
    PubMed     Text format     Abstract available


  195. VILASECA I, Nogues-Sabate A, Aviles-Jurado FX, Berenguer J, et al
    Factors of local recurrence and organ preservation with transoral laser microsurgery in laryngeal carcinomas; CHAID decision-tree analysis.
    Head Neck. 2018 Dec 6. doi: 10.1002/hed.25422.
    PubMed     Text format     Abstract available


  196. VON DER GRUN J, Kohn J, Loutfi-Krauss B, Blanck O, et al
    Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2max ) of >180 Gy for patients with recurrent head and neck cancer.
    Head Neck. 2018 Dec 6. doi: 10.1002/hed.25428.
    PubMed     Text format     Abstract available


    November 2018
  197. PAGEDAR NA, Fowlkes JW, Sheffield AM
    Operative technique: Lateral neck dissection.
    Head Neck. 2018 Nov 26. doi: 10.1002/hed.25348.
    PubMed     Text format    


  198. WONG ET, Dmytriw AA, Yu E, Waldron J, et al
    (18) F-FDG PET/CT for locoregional surveillance following definitive treatment of head and neck cancer: A meta-analysis of reported studies.
    Head Neck. 2018 Nov 20. doi: 10.1002/hed.25513.
    PubMed     Text format     Abstract available


  199. BOSSI P, Miceli R, Benasso M, Corvo R, et al
    Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials.
    Head Neck. 2018 Nov 17. doi: 10.1002/hed.25389.
    PubMed     Text format     Abstract available


  200. PARK JC, Gourin CG, Kiess AP, Mehra R, et al
    Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States.
    Head Neck. 2018 Nov 13. doi: 10.1002/hed.25333.
    PubMed     Text format     Abstract available


  201. TRUONG AT, Truong DT, Rahlfs TF
    TRS score: A proposed mnemonic for airway assessment and management in patients with head and neck cancers.
    Head Neck. 2018 Nov 2. doi: 10.1002/hed.25502.
    PubMed     Text format    


    October 2018
  202. ANSCHUETZ L, Visini M, Shelan M, Elicin O, et al
    Risk analysis for tracheostomy dependency in curatively treated laryngeal cancer with organ preservation.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25373.
    PubMed     Text format     Abstract available


  203. LEON X, Pardo L, Sansa A, Fernandez A, et al
    Prognostic role of extracapsular spread in planned neck dissection after chemoradiotherapy.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25390.
    PubMed     Text format     Abstract available


  204. ZHANG N, Fielding R, Soong I, Chan KK, et al
    Illness perceptions as predictors of psychological distress among head and neck cancer survivors: a longitudinal study.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25343.
    PubMed     Text format     Abstract available


  205. KILIC S, Kilic SS, Hsueh WD, Eloy JA, et al
    Radiotherapy modality as a predictor of survival in hypopharyngeal cancer.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25360.
    PubMed     Text format     Abstract available


  206. SON HJ, Kim JK, Jung YD, Jang GH, et al
    Comparison of outcomes between hemithyroidectomy alone and hemithyroidectomy with elective unilateral central neck dissection in patients with papillary thyroid microcarcinoma.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25354.
    PubMed     Text format     Abstract available


  207. KOGASHIWA Y, Inoue H, Kuba K, Araki R, et al
    Prognostic role of epiregulin/amphiregulin expression in recurrent/metastatic head and neck cancer treated with cetuximab.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25353.
    PubMed     Text format     Abstract available


  208. HAMILTON SN, Tran E, Berthelet E, Wu J, et al
    Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: A population-based analysis.
    Head Neck. 2018 Oct 8. doi: 10.1002/hed.25352.
    PubMed     Text format     Abstract available


    September 2018
  209. SCRIMGER RA, Seikaly H, Vos LJ, Harris J, et al
    Combination of submandibular salivary gland transfer and intensity-modulated radiotherapy to reduce dryness of mouth (xerostomia) in patients with head and neck cancer.
    Head Neck. 2018 Sep 3. doi: 10.1002/hed.25339.
    PubMed     Text format     Abstract available


    August 2018
  210. DOMINGUES CSDC, Serambeque BP, Laranjo Candido MS, Marto CMM, et al
    Epithelial-mesenchymal transition and microRNAs: Challenges and future perspectives in oral cancer.
    Head Neck. 2018 Aug 18. doi: 10.1002/hed.25381.
    PubMed     Text format     Abstract available


  211. TAKENAKA Y, Oya R, Kitamiura T, Ashida N, et al
    Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2018 Aug 13. doi: 10.1002/hed.25366.
    PubMed     Text format     Abstract available


  212. KARATAS OF
    Antiproliferative potential of miR-33a in laryngeal cancer Hep-2 cells via targeting PIM1.
    Head Neck. 2018 Aug 13. doi: 10.1002/hed.25361.
    PubMed     Text format     Abstract available


    July 2018
  213. HONG YT, Hong KH
    Identification of lymphatic channels in the tracheoesophageal groove during central neck dissection for thyroid cancer.
    Head Neck. 2018 Jul 26. doi: 10.1002/hed.25125.
    PubMed     Text format     Abstract available


    June 2018
  214. MARIONI G, Cappellesso R, Ottaviano G, Fasanaro E, et al
    Nuclear nonmetastatic protein 23-H1 expression and epithelial-mesenchymal transition in laryngeal carcinoma: A pilot investigation.
    Head Neck. 2018 Jun 28. doi: 10.1002/hed.25188.
    PubMed     Text format     Abstract available


  215. LEBO NL, Griffiths R, Hall S, Dimitroulakos J, et al
    Effect of statin use on oncologic outcomes in head and neck squamous cell carcinoma.
    Head Neck. 2018 Jun 22. doi: 10.1002/hed.25152.
    PubMed     Text format     Abstract available


  216. OOFT ML, van Ipenburg J, van de Loo RJM, de Jong R, et al
    Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma.
    Head Neck. 2018 Jun 21. doi: 10.1002/hed.25195.
    PubMed     Text format     Abstract available


    May 2018
  217. THAM T, Bardash Y, Herman SW, Costantino PD, et al
    Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2018 May 14. doi: 10.1002/hed.25324.
    PubMed     Text format     Abstract available


  218. WU JS, Tsai YC, Jian JJ, Chen HH, et al
    Survival without adjuvant chemotherapy for selected patients with stage II and III nasopharyngeal carcinoma after concurrent chemoradiotherapy alone.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25205.
    PubMed     Text format     Abstract available


  219. LANDEEN KC, Spanos WC, Gromer L
    Topical superoxide dismutase in posttreatment fibrosis in patients with head and neck cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25119.
    PubMed     Text format     Abstract available


  220. ANDERSON NJ, Jackson JE, Smith JG, Wada M, et al
    Pretreatment risk stratification of feeding tube use in patients treated with intensity-modulated radiotherapy for head and neck cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25316.
    PubMed     Text format     Abstract available


  221. TRIVEDI NP
    Oral cancer involving masticator space (T4b): Review of literature and future directions.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25211.
    PubMed     Text format     Abstract available


  222. SUCCO G, Crosetti E, Bertolin A, Piazza C, et al
    Treatment for T3 to T4a laryngeal cancer by open partial horizontal laryngectomies: Prognostic impact of different pathologic tumor subcategories.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25176.
    PubMed     Text format     Abstract available


  223. ALAHMAD YM, Aljaber M, Saleh AI, Yalcin HC, et al
    Effect of cell-phone radiofrequency on angiogenesis and cell invasion in human head and neck cancer cells.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25210.
    PubMed     Text format     Abstract available


  224. SONG JSA, Moolman N, Burrell S, Rajaraman M, et al
    Use of radioiodine-131 scan to measure influence of surgical discipline, practice, and volume on residual thyroid tissue after total thyroidectomy for differentiated thyroid carcinoma.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25204.
    PubMed     Text format     Abstract available


  225. MULCAHY CF, Mohamed ASR, Kanwar A, Hutcheson KA, et al
    Age-adjusted comorbidity and survival in locally advanced laryngeal cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25200.
    PubMed     Text format     Abstract available


  226. ONO T, Azuma K, Kawahara A, Sasada T, et al
    Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25189.
    PubMed     Text format     Abstract available


    April 2018
  227. NAIR D, Mair M, Singhvi H, Mishra A, et al
    Perineural invasion: Independent prognostic factor in oral cancer that warrants adjuvant treatment.
    Head Neck. 2018 Apr 29. doi: 10.1002/hed.25170.
    PubMed     Text format     Abstract available


  228. HO JC, Phan J
    Reirradiation of head and neck cancer using modern highly conformal techniques.
    Head Neck. 2018 Apr 23. doi: 10.1002/hed.25180.
    PubMed     Text format     Abstract available


  229. BERNSTEIN LJ, Pond GR, Gan HK, Tirona K, et al
    Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort.
    Head Neck. 2018 Apr 17. doi: 10.1002/hed.25198.
    PubMed     Text format     Abstract available


  230. FAN CY, Jen YM, Su YC, Chao HL, et al
    Association between nasopharyngeal carcinoma and risk of optic neuropathy: A population-based cohort study.
    Head Neck. 2018 Apr 16. doi: 10.1002/hed.25177.
    PubMed     Text format     Abstract available


    March 2018
  231. SHINGLER E, Robles LA, Perry R, Penfold C, et al
    Systematic review evaluating randomized controlled trials of smoking and alcohol cessation interventions in people with head and neck cancer and oral dysplasia.
    Head Neck. 2018 Mar 30. doi: 10.1002/hed.25138.
    PubMed     Text format     Abstract available


  232. HAQUE SU, Niu L, Kuhnell D, Hendershot J, et al
    Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 25. doi: 10.1002/hed.25136.
    PubMed     Text format     Abstract available


  233. HEGDE JV, Demanes DJ, Veruttipong D, Chin RK, et al
    Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25137.
    PubMed     Text format     Abstract available


  234. KIM HK, Lee I, Lee J, Chang HS, et al
    BRAF(wild) papillary thyroid carcinoma has two distinct mRNA expression patterns with different clinical behaviors.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25151.
    PubMed     Text format     Abstract available


  235. RHOTEN BA, Murphy BA, Dietrich MS, Ridner SH, et al
    Depressive symptoms, social anxiety, and perceived neck function in patients with head and neck cancer.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25129.
    PubMed     Text format     Abstract available


  236. LUCIONI M, Lionello M, Salis G, Bertolin A, et al
    Bocca's hemipharyngo-total laryngectomy for hypopharyngeal carcinoma to avoid reconstruction with a pedicled flap.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25124.
    PubMed     Text format     Abstract available


  237. CONDELLO V, Macerola E, Ugolini C, De Napoli L, et al
    Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma.
    Head Neck. 2018 Mar 22. doi: 10.1002/hed.25155.
    PubMed     Text format     Abstract available


  238. MCEWEN SE, Dunphy C, Rios JN, Davis AM, et al
    Evaluation of a rehabilitation planning consult for survivors of head and neck cancer.
    Head Neck. 2018 Mar 22. doi: 10.1002/hed.25113.
    PubMed     Text format     Abstract available


  239. PAYNE K, Spruce R, Beggs A, Sharma N, et al
    Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 15. doi: 10.1002/hed.25140.
    PubMed     Text format     Abstract available


  240. WANG CI, Yu CJ, Huang Y, Yi JS, et al
    Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1beta-induced matrix metalloproteinase expression in oral cancer.
    Head Neck. 2018 Mar 15. doi: 10.1002/hed.25145.
    PubMed     Text format     Abstract available


  241. KIM H, Vargo JA, Beriwal S, Clump DA, et al
    Cost-effectiveness analysis of salvage therapies in locoregional previously irradiated head and neck cancer.
    Head Neck. 2018 Mar 14. doi: 10.1002/hed.25142.
    PubMed     Text format     Abstract available


  242. SUZUKI S, Yasunaga H, Matsui H, Fushimi K, et al
    Postoperative mechanical bowel obstruction after pharyngolaryngectomy for hypopharyngeal cancer: Retrospective analysis using a Japanese inpatient database.
    Head Neck. 2018 Mar 14. doi: 10.1002/hed.25139.
    PubMed     Text format     Abstract available


  243. YU F, Lu Y, Petersson F, Wang DY, et al
    Presence of lytic Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25131.
    PubMed     Text format     Abstract available


  244. DAHER T, Tur MK, Brobeil A, Etschmann B, et al
    Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25041.
    PubMed     Text format     Abstract available


  245. WANG X, Li Y, Gao Y, Ouyang D, et al
    Second primary squamous cell carcinoma in patients with nasopharyngeal carcinoma after radiotherapy predictors and prognostic factors.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25130.
    PubMed     Text format     Abstract available


  246. MIZUSHIMA T, Ohnishi S, Shimizu Y, Hatanaka Y, et al
    Rapid detection of superficial head and neck squamous cell carcinoma by topically spraying fluorescent probe targeting dipeptidyl peptidase-IV.
    Head Neck. 2018 Mar 6. doi: 10.1002/hed.25126.
    PubMed     Text format     Abstract available


  247. VUONG HG, Odate T, Duong UNP, Mochizuki K, et al
    Prognostic importance of solid variant papillary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2018 Mar 6. doi: 10.1002/hed.25123.
    PubMed     Text format     Abstract available


  248. LU J, Chen XM, Huang HR, Zhao FP, et al
    Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma.
    Head Neck. 2018 Mar 1. doi: 10.1002/hed.25104.
    PubMed     Text format     Abstract available


    February 2018
  249. PENFOLD CM, Thomas SJ, Waylen A, Ness AR, et al
    Change in alcohol and tobacco consumption after a diagnosis of head and neck cancer: Findings from head and neck 5000.
    Head Neck. 2018 Feb 27. doi: 10.1002/hed.25116.
    PubMed     Text format     Abstract available


  250. HAMSTRA DA, Lee KC, Eisbruch A, Sunkara P, et al
    Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer.
    Head Neck. 2018 Feb 23. doi: 10.1002/hed.25115.
    PubMed     Text format     Abstract available


  251. DANILOVIC DLS, de Mello ES, Frazzato EST, Wakamatsu A, et al
    Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma.
    Head Neck. 2018 Feb 22. doi: 10.1002/hed.25105.
    PubMed     Text format     Abstract available


  252. MORISADA M, Chamberlin M, Allen C
    Exploring the rationale for combining ionizing radiation and immune checkpoint blockade in head and neck cancer.
    Head Neck. 2018 Feb 20. doi: 10.1002/hed.25101.
    PubMed     Text format     Abstract available


  253. OSBORN VW, Givi B, Rineer J, Roden D, et al
    Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.
    Head Neck. 2018 Feb 16. doi: 10.1002/hed.25103.
    PubMed     Text format     Abstract available


  254. CHAN SL, Ng LS, Goh X, Siow CH, et al
    Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population.
    Head Neck. 2018 Feb 16. doi: 10.1002/hed.25112.
    PubMed     Text format     Abstract available


  255. GINGERICH MA, Smith JD, Michmerhuizen NL, Ludwig M, et al
    Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patients.
    Head Neck. 2018 Feb 10. doi: 10.1002/hed.25057.
    PubMed     Text format     Abstract available


  256. YOSHIDA EJ, Luu M, David JM, Kim S, et al
    Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25100.
    PubMed     Text format     Abstract available


  257. KIRKE DN, Qureshi MM, Kamran SC, Ezzat W, et al
    Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25087.
    PubMed     Text format     Abstract available


  258. MURTHY SP, Balasubramanian D, Subramaniam N, Nair G, et al
    Prevalence of adverse pathological features in 1 to 4 cm low-risk differentiated thyroid carcinoma.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25099.
    PubMed     Text format     Abstract available


  259. HALL SF, Griffiths RJ
    Evaluation of treatment outcomes in patients with supraglottic laryngeal cancer in Ontario, Canada: A population-based study.
    Head Neck. 2018 Feb 7. doi: 10.1002/hed.25073.
    PubMed     Text format     Abstract available


  260. BACK LJJ, Aro K, Tapiovaara L, Vikatmaa P, et al
    Sacrifice and extracranial reconstruction of the common or internal carotid artery in advanced head and neck carcinoma: Review and meta-analysis.
    Head Neck. 2018 Feb 5. doi: 10.1002/hed.25093.
    PubMed     Text format     Abstract available


  261. GUTTMANN DM, Kobie J, Grover S, Lin A, et al
    National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival.
    Head Neck. 2018 Feb 2. doi: 10.1002/hed.25091.
    PubMed     Text format     Abstract available


  262. TALMI YP, Takes RP, Alon EE, Nixon IJ, et al
    Prognostic value of lymph node ratio in head and neck squamous cell carcinoma.
    Head Neck. 2018 Feb 2. doi: 10.1002/hed.25080.
    PubMed     Text format     Abstract available


  263. LIN PJ, Twu CW, Liu YC, Lin TY, et al
    Comparison the clinical outcomes with altered versus conventional fractionated radiotherapy plus concurrent chemotherapy for advanced nasopharyngeal carcinoma.
    Head Neck. 2018 Feb 1. doi: 10.1002/hed.25084.
    PubMed     Text format     Abstract available


  264. TIRELLI G, Bergamini PR, Scardoni A, Gatto A, et al
    Intraoperative monitoring of marginal mandibular nerve during neck dissection.
    Head Neck. 2018 Feb 1. doi: 10.1002/hed.25078.
    PubMed     Text format     Abstract available


    January 2018
  265. VALLS-MATEUS M, Nogues-Sabate A, Blanch JL, Bernal-Sprekelsen M, et al
    Narrow band imaging for head and neck malignancies: Lessons learned from mistakes.
    Head Neck. 2018 Jan 31. doi: 10.1002/hed.25088.
    PubMed     Text format     Abstract available


  266. NAKAYAMA M, Gosho M, Hirose Y, Nishimura B, et al
    Modified combination of platelet count and neutrophil "to" lymphocyte ratio as a prognostic factor in patients with advanced head and neck cancer.
    Head Neck. 2018 Jan 31. doi: 10.1002/hed.25085.
    PubMed     Text format     Abstract available


  267. ZENGA J, Pipkorn P, Graboyes EM, Martin EJ, et al
    Oncologic outcomes of extended neck dissections in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Head Neck. 2018 Jan 29. doi: 10.1002/hed.25060.
    PubMed     Text format     Abstract available


  268. AEBERHARD C, Mayer C, Meyer S, Mueller SA, et al
    Effect of preoperative immunonutrition on postoperative short-term outcomes of patients with head and neck squamous cell carcinoma.
    Head Neck. 2018 Jan 24. doi: 10.1002/hed.25072.
    PubMed     Text format     Abstract available


  269. VASAN K, Low TH, Gupta R, Ashford B, et al
    Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma.
    Head Neck. 2018 Jan 23. doi: 10.1002/hed.25066.
    PubMed     Text format     Abstract available


  270. LAM JKS, Sundaresan P, Gebski V, Veness MJ, et al
    Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: Poor outcome unrelated to the index lesion.
    Head Neck. 2018 Jan 23. doi: 10.1002/hed.25069.
    PubMed     Text format     Abstract available


  271. BAUMEISTER P, Baumuller K, Harreus U, Reiter M, et al
    Evaluation of margins in head and neck squamous cell carcinoma from the surgeon's perspective.
    Head Neck. 2018 Jan 22. doi: 10.1002/hed.25061.
    PubMed     Text format     Abstract available


  272. MASCARELLA MA, Mannard E, Daniela Silva Wurzba S, Zeitouni A, et al
    Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta-analysis.
    Head Neck. 2018 Jan 22. doi: 10.1002/hed.25075.
    PubMed     Text format     Abstract available


  273. ESKANDER A, Strigenz D, Seim N, Ozer E, et al
    Submental artery island flap with simultaneous level I neck dissection.
    Head Neck. 2018 Jan 13. doi: 10.1002/hed.25044.
    PubMed     Text format     Abstract available


  274. REN Y, Deschler DG, Sajed D, Durand ML, et al
    Case of late-onset, relapsing surgical site infection related to a venous coupler placed during free flap reconstruction for major head and neck cancer.
    Head Neck. 2018 Jan 12. doi: 10.1002/hed.25043.
    PubMed     Text format     Abstract available


  275. SATHASIVAM HP, Davies GR, Boyd NM
    Predictive factors for osteoradionecrosis of the jaws: A retrospective study.
    Head Neck. 2018;40:46-54.
    PubMed     Text format     Abstract available


  276. CHENG SJ, Ko HH, Lee JJ, Kok SH, et al
    Comparison of long-term outcomes between pull-through resection and mandibular lip-split surgery for T4a tongue/floor of mouth cancers.
    Head Neck. 2018;40:144-153.
    PubMed     Text format     Abstract available


  277. MAYROVITZ HN, Ryan S, Hartman JM
    Usability of advanced pneumatic compression to treat cancer-related head and neck lymphedema: A feasibility study.
    Head Neck. 2018;40:137-143.
    PubMed     Text format     Abstract available


  278. GROSELJ A, Bosnjak M, Strojan P, Krzan M, et al
    Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary results.
    Head Neck. 2018;40:120-125.
    PubMed     Text format     Abstract available


  279. KANG JH, Jung DW, Pak KJ, Kim IJ, et al
    Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Head Neck. 2018;40:94-102.
    PubMed     Text format     Abstract available


  280. OKER N, Verillaud B, Wassef M, Froelich S, et al
    Ethmoidal adenocarcinoma treated by exclusive endoscopic approach: Focus on learning curve and modification of management.
    Head Neck. 2018;40:126-136.
    PubMed     Text format     Abstract available


  281. WONG EHC, Tetter N, Tzankov A, Muller L, et al
    CASTLE tumor of the parotid: First documented case, literature review, and genetic analysis of the cancer.
    Head Neck. 2018;40:E1-E4.
    PubMed     Text format     Abstract available


  282. PARK I, Her N, Choe JH, Kim JS, et al
    Management of chyle leakage after thyroidectomy, cervical lymph node dissection, in patients with thyroid cancer.
    Head Neck. 2018;40:7-15.
    PubMed     Text format     Abstract available


  283. MCCLELLAN J, Achim V, Clayburgh D
    Small bowel obstruction after transoral robotic surgery.
    Head Neck. 2018;40:E9-E12.
    PubMed     Text format     Abstract available


  284. SO YK, Oh D, Choi N, Baek CH, et al
    Efficacy of postoperative neck irradiation for regional control in patients with pN0 oral tongue cancer: Propensity analysis.
    Head Neck. 2018;40:163-169.
    PubMed     Text format     Abstract available


  285. ARO K, Tarkkanen J, Saat R, Saarilahti K, et al
    Submandibular gland cancer: Specific features and treatment considerations.
    Head Neck. 2018;40:154-162.
    PubMed     Text format     Abstract available


  286. MATTAVELLI D, Schreiber A, Villaret AB, Accorona R, et al
    Complications and donor site morbidity of 3-layer reconstruction with iliotibial tract of the anterior skull base: Retrospective analysis of 186 patients.
    Head Neck. 2018;40:63-69.
    PubMed     Text format     Abstract available


  287. LANSU J, Klop WM, Heemsbergen W, Navran A, et al
    Local control in sinonasal malignant melanoma: Comparing conventional to hypofractionated radiotherapy.
    Head Neck. 2018;40:86-93.
    PubMed     Text format     Abstract available


  288. HONG MH, Kim CG, Koh YW, Choi EC, et al
    Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck.
    Head Neck. 2018;40:55-62.
    PubMed     Text format     Abstract available


  289. MEYER A, Gross N, Teng M
    AHNS Series: Do you know your guidelines? Perioperative antithrombotic management in head and neck surgery.
    Head Neck. 2018;40:182-191.
    PubMed     Text format     Abstract available


  290. PENA I, Clayman GL, Grubbs EG, Bergeron JM Jr, et al
    Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.
    Head Neck. 2018;40:79-85.
    PubMed     Text format     Abstract available


    December 2017
  291. AVINCSAL MO, Shinomiya H, Teshima M, Kubo M, et al
    Impact of alcohol dehydrogenase-aldehyde dehydrogenase polymorphism on clinical outcome in patients with hypopharyngeal cancer.
    Head Neck. 2017 Dec 29. doi: 10.1002/hed.25050.
    PubMed     Text format     Abstract available


  292. DEJACO D, Steinbichler T, Schartinger VH, Fischer N, et al
    Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgery.
    Head Neck. 2017 Dec 22. doi: 10.1002/hed.25040.
    PubMed     Text format     Abstract available


  293. SON HJ, Roh JL, Choi SH, Nam SY, et al
    Nutritional and hematologic markers as predictors of risk of surgical site infection in patients with head and neck cancer undergoing major oncologic surgery.
    Head Neck. 2017 Dec 5. doi: 10.1002/hed.25031.
    PubMed     Text format     Abstract available


  294. SANABRIA A, Kowalski LP, Shah JP, Nixon IJ, et al
    Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.
    Head Neck. 2017 Dec 5. doi: 10.1002/hed.25029.
    PubMed     Text format     Abstract available


    November 2017
  295. FULCHER CD, Haigentz M Jr, Ow TJ
    AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.
    Head Neck. 2017 Nov 24. doi: 10.1002/hed.25025.
    PubMed     Text format     Abstract available


  296. ESKANDER A, Ghanem T, Agrawal A
    AHNS Series: Do you know your guidelines? Guideline recommendations for head and neck cancer of unknown primary site.
    Head Neck. 2017 Nov 21. doi: 10.1002/hed.25026.
    PubMed     Text format     Abstract available


  297. CAO C, Hu Q, Chen X
    Intensity-modulated radiotherapy for elderly patients with nasopharyngeal carcinoma.
    Head Neck. 2017 Nov 20. doi: 10.1002/hed.25016.
    PubMed     Text format     Abstract available


  298. WONG DJY, Donaldson C, Lai LT, Coleman A, et al
    Safety and effectiveness of endovascular embolization or stent-graft reconstruction for treatment of acute carotid blowout syndrome in patients with head and neck cancer: Case series and systematic review of observational studies.
    Head Neck. 2017 Nov 20. doi: 10.1002/hed.25018.
    PubMed     Text format     Abstract available


  299. LECHELT LA, Rieger JM, Cowan K, Debenham BJ, et al
    Top 10 research priorities in head and neck cancer: Results of an Alberta priority setting partnership of patients, caregivers, family members, and clinicians.
    Head Neck. 2017 Nov 17. doi: 10.1002/hed.24998.
    PubMed     Text format     Abstract available


  300. MAYS AC, Bartels HG, Wistermayer PR, Rohlfing ML, et al
    Potential for health care cost savings with preoperative gastrostomy tube placement in the head and neck cancer population.
    Head Neck. 2017 Nov 13. doi: 10.1002/hed.24992.
    PubMed     Text format     Abstract available


  301. LEONG YH, Soon YY, Lee KM, Wong LC, et al
    Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis.
    Head Neck. 2017 Nov 11. doi: 10.1002/hed.24993.
    PubMed     Text format     Abstract available


  302. DAVIDI ES, Dreifuss T, Motiei M, Shai E, et al
    Cisplatin-conjugated gold nanoparticles as a theranostic agent for head and neck cancer.
    Head Neck. 2017 Nov 11. doi: 10.1002/hed.24935.
    PubMed     Text format     Abstract available


  303. KAMSTRA JI, van Leeuwen M, Roodenburg JLN, Dijkstra PU, et al
    Exercise therapy for trismus secondary to head and neck cancer: A systematic review.
    Head Neck. 2017;39:2352-2362.
    PubMed     Text format     Abstract available


    October 2017
  304. CHAN JYW, Wong STS, Wei WI
    Stage II recurrent nasopharyngeal carcinoma: Prognostic significance of retropharyngeal nodal metastasis, parapharyngeal invasion, and carotid encasement.
    Head Neck. 2017 Oct 30. doi: 10.1002/hed.24976.
    PubMed     Text format     Abstract available


  305. TAMAKI A, Miles BA, Lango M, Kowalski L, et al
    AHNS Series: Do you know your guidelines? Review of current knowledge on laryngeal cancer.
    Head Neck. 2017 Oct 27. doi: 10.1002/hed.24862.
    PubMed     Text format     Abstract available


  306. TAKENAKA Y, Oya R, Kitamiura T, Ashida N, et al
    Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.
    Head Neck. 2017 Oct 27. doi: 10.1002/hed.24986.
    PubMed     Text format     Abstract available


  307. PENG S, Wu C, Sun W, Liu D, et al
    Snail-mediated cancer stem cell-like phenotype in human CNE2 nasopharyngeal carcinoma cell.
    Head Neck. 2017 Oct 12. doi: 10.1002/hed.24982.
    PubMed     Text format     Abstract available


  308. HUANG WB, Wong STS, Chan JYW
    Role of surgery in the treatment of osteoradionecrosis and its complications after radiotherapy for nasopharyngeal carcinoma.
    Head Neck. 2017 Oct 9. doi: 10.1002/hed.24973.
    PubMed     Text format     Abstract available


  309. LIU JC
    Head and Neck Cancer, Multimodality Management, 2nd ed, Editor: Jacques Bernier Jeffrey C. Liu Springer, Switzerland, 2016, USD $329, 878 pages.
    Head Neck. 2017 Oct 5. doi: 10.1002/hed.24920.
    PubMed     Text format    


    September 2017
  310. FAN CY, Chao HL, Lin CS, Huang WY, et al
    Risk of depressive disorder among patients with head and neck cancer: A nationwide population-based study.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24961.
    PubMed     Text format     Abstract available


  311. LECHIEN JR, Nassri A, Kindt N, Brown DN, et al
    Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24939.
    PubMed     Text format     Abstract available


  312. ONG HS, Gokavarapu S, Al-Qamachi L, Yin MY, et al
    Justification of routine venous thromboembolism prophylaxis in head and neck cancer reconstructive surgery.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24914.
    PubMed     Text format     Abstract available


  313. BURNS CL, Kularatna S, Ward EC, Hill AJ, et al
    Cost analysis of a speech pathology synchronous telepractice service for patients with head and neck cancer.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24916.
    PubMed     Text format     Abstract available


  314. LOMBARDI D, Paderno A, Giordano D, Barbieri D, et al
    Therapeutic lateral neck dissection in well-differentiated thyroid cancer: Analysis on factors predicting distribution of positive nodes and prognosis.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24936.
    PubMed     Text format     Abstract available


  315. AVILES-JURADO FX, Flores JC, Guma J, Ceperuelo-Mallafre V, et al
    Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24919.
    PubMed     Text format     Abstract available


  316. QIU J, Lv B, Fu M, Wang X, et al
    18 F-Fluoromisonidazole positron emission tomography/CT-guided volumetric-modulated arc therapy-based dose escalation for hypoxic subvolume in nasopharyngeal carcinomas: A feasibility study.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24925.
    PubMed     Text format     Abstract available


  317. LIU H, Zhang Y, Zhang T, Li F, et al
    Correlation between the pathology and clinical presentations in patients with adenoid cystic carcinoma of the external auditory canal.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24915.
    PubMed     Text format     Abstract available


  318. KAWAKITA D, Lee YA, Li Q, Chen Y, et al
    Impact of oral hygiene on head and neck cancer risk in a Chinese population.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24929.
    PubMed     Text format     Abstract available


  319. LUCIONI M, D'Ascanio L, De Nardi E, Lionello M, et al
    Management of paratracheal lymph nodes in laryngeal cancer with subglottic involvement.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24905.
    PubMed     Text format     Abstract available


  320. CHENG SJ, Chang CF, Ko HH, Lee JJ, et al
    Hypermethylated ZNF582 and PAX1 genes in mouth rinse samples as biomarkers for oral dysplasia and oral cancer detection.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24958.
    PubMed     Text format     Abstract available


  321. ITO M, Kodaira T, Tachibana H, Tomita N, et al
    Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24909.
    PubMed     Text format     Abstract available


  322. ZHANG H, Kim S, Chen Z, Nannapaneni S, et al
    Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
    Head Neck. 2017 Sep 25. doi: 10.1002/hed.24911.
    PubMed     Text format     Abstract available


  323. DA FONSECA FL, Yamanaka PK, Mazoti L, Arakawa-Sugueno L, et al
    Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study.
    Head Neck. 2017 Sep 25. doi: 10.1002/hed.24895.
    PubMed     Text format     Abstract available


    August 2017
  324. BERWOUTS D, Madani I, Duprez F, Olteanu AL, et al
    Long-term outcome of 18 F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study.
    Head Neck. 2017 Aug 21. doi: 10.1002/hed.24892.
    PubMed     Text format     Abstract available


  325. DE BREE R, Wolf GT, de Keizer B, Nixon IJ, et al
    Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.
    Head Neck. 2017 Aug 17. doi: 10.1002/hed.24883.
    PubMed     Text format     Abstract available


  326. KAWADA T, Takahashi H, Sakakura K, Ida S, et al
    Circulating tumor cells in patients with head and neck squamous cell carcinoma: Feasibility of detection and quantitation.
    Head Neck. 2017 Aug 17. doi: 10.1002/hed.24893.
    PubMed     Text format     Abstract available


  327. FANELLI MF, Oliveira TB, Braun AC, Corassa M, et al
    Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor-beta receptor I in head and neck cancer.
    Head Neck. 2017 Aug 17. doi: 10.1002/hed.24899.
    PubMed     Text format     Abstract available


  328. LACCOURREYE O, Bonfils P, Malinvaud D, Menard M, et al
    Survival and laryngeal preservation tradeoff in advanced laryngeal cancer: From the otorhinolaryngology patient to the managing physician.
    Head Neck. 2017 Aug 8. doi: 10.1002/hed.24833.
    PubMed     Text format     Abstract available


  329. KRAAIJENGA SAC, Molen LV, Stuiver MM, Takes RP, et al
    Efficacy of a novel swallowing exercise program for chronic dysphagia in long-term head and neck cancer survivors.
    Head Neck. 2017 Aug 2. doi: 10.1002/hed.24710.
    PubMed     Text format     Abstract available


  330. ASTRUP GL, Rustoen T, Hofso K, Gran JM, et al
    Symptom burden and patient characteristics: Association with quality of life in patients with head and neck cancer undergoing radiotherapy.
    Head Neck. 2017 Aug 2. doi: 10.1002/hed.24875.
    PubMed     Text format     Abstract available


    July 2017
  331. GREEN R, Macmillan MT, Tikka T, Bruce L, et al
    Analysis of the incidence and factors predictive of outcome in patients with head and neck cancer with pulmonary nodules.
    Head Neck. 2017 Jul 25. doi: 10.1002/hed.24885.
    PubMed     Text format     Abstract available


  332. KO HC, Chen S, Wieland AM, Yu M, et al
    Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database.
    Head Neck. 2017 Jul 24. doi: 10.1002/hed.24881.
    PubMed     Text format     Abstract available


  333. MALIK A, Sahu A, Singh SP, Deshmukh A, et al
    In vivo Raman spectroscopy-assisted early identification of potential second primary/recurrences in oral cancers: An exploratory study.
    Head Neck. 2017 Jul 24. doi: 10.1002/hed.24884.
    PubMed     Text format     Abstract available


  334. MARINA M, Ceda GP, Corcione L, Sgargi P, et al
    Size of thyroid carcinoma by histotype and variants: A population-based study in a mildly iodine-deficient area.
    Head Neck. 2017 Jul 24. doi: 10.1002/hed.24877.
    PubMed     Text format     Abstract available


  335. CZERWONKA L, Bissada E, Goldstein DP, Wood RE, et al
    High-resolution cone-beam computed tomography for assessment of bone invasion in oral cancer: Comparison with conventional computed tomography.
    Head Neck. 2017 Jul 12. doi: 10.1002/hed.24858.
    PubMed     Text format     Abstract available


  336. CHENG CT, Lin CY, Hung-Chun Cheng S, Lin YP, et al
    Survival benefit of surgical approach for advanced oropharyngeal and hypopharyngeal cancer: A retrospective analysis.
    Head Neck. 2017 Jul 10. doi: 10.1002/hed.24869.
    PubMed     Text format     Abstract available


  337. CHANG PH, Yeh KY, Wang CH, Chen EY, et al
    Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
    Head Neck. 2017 Jul 7. doi: 10.1002/hed.24853.
    PubMed     Text format     Abstract available


  338. FLETCHER KT, Gal TJ, Ebelhar AJ, Valentino J, et al
    Prognostic indicators and survival in salvage surgery for laryngeal cancer.
    Head Neck. 2017 Jul 6. doi: 10.1002/hed.24860.
    PubMed     Text format     Abstract available


  339. SHAH-BECKER S, Pennock M, Sinoway L, Goldenberg D, et al
    Baroreceptor reflex failure: Review of the literature and the potential impact on patients with head and neck cancer.
    Head Neck. 2017 Jul 4. doi: 10.1002/hed.24857.
    PubMed     Text format     Abstract available


    June 2017
  340. DUPREZ F, Berwouts D, De Neve W, Bonte K, et al
    Distant metastases in head and neck cancer.
    Head Neck. 2017 Jun 26. doi: 10.1002/hed.24687.
    PubMed     Text format     Abstract available


  341. REID PA, Wilson P, Li Y, Marcu LG, et al
    Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.
    Head Neck. 2017 Jun 23. doi: 10.1002/hed.24848.
    PubMed     Text format     Abstract available


  342. MASSA ST, Cass LM, Osazuwa-Peters N, Christopher KM, et al
    Decreased cancer-independent life expectancy in the head and neck cancer population.
    Head Neck. 2017 Jun 22. doi: 10.1002/hed.24850.
    PubMed     Text format     Abstract available


  343. VILASECA I, Valls-Mateus M, Nogues A, Lehrer E, et al
    Usefulness of office examination with narrow band imaging for the diagnosis of head and neck squamous cell carcinoma and follow-up of premalignant lesions.
    Head Neck. 2017 Jun 22. doi: 10.1002/hed.24849.
    PubMed     Text format     Abstract available


  344. TING Y, Chee J, Charn TC, Loh KS, et al
    Prognostic significance of cystic lymph nodal metastasis in nasopharyngeal carcinoma.
    Head Neck. 2017 Jun 22. doi: 10.1002/hed.24844.
    PubMed     Text format     Abstract available


  345. BARBER B, Harris J, Shillington C, Rychlik S, et al
    Efficacy of a high-observation protocol in major head and neck cancer surgery: A prospective study.
    Head Neck. 2017 Jun 20. doi: 10.1002/hed.24599.
    PubMed     Text format     Abstract available


  346. ESKANDER A, Mifsud M, Irish J, Gullane P, et al
    Overview of surgery for laryngeal and hypopharyngeal cancer in Ontario, 2003-2010.
    Head Neck. 2017 Jun 7. doi: 10.1002/hed.24787.
    PubMed     Text format     Abstract available


  347. TAMJID B, Phan P, John T, Mitchell P, et al
    Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer.
    Head Neck. 2017 Jun 7. doi: 10.1002/hed.24751.
    PubMed     Text format     Abstract available


  348. MOHANTI BK, Thakar A, Kaur J, Bahadur S, et al
    Postoperative radiotherapy dose requirement in standard combined-modality practice for head and neck squamous cell carcinoma: Analysis of salient surgical and radiotherapy parameters in 2 cohorts.
    Head Neck. 2017 Jun 6. doi: 10.1002/hed.24836.
    PubMed     Text format     Abstract available


  349. SAITO Y, Omura G, Yasuhara K, Rikitake R, et al
    Prognostic value of lymphovascular invasion of the primary tumor in hypopharyngeal carcinoma after total laryngopharyngectomy.
    Head Neck. 2017 Jun 5. doi: 10.1002/hed.24705.
    PubMed     Text format     Abstract available


  350. D'SOUZA W, Pradhan S, Saranath D
    Multiple single nucleotide polymorphism analysis and association of specific genotypes in FHIT, SAMD4A, and ANKRD17 in Indian patients with oral cancer.
    Head Neck. 2017 Jun 5. doi: 10.1002/hed.24798.
    PubMed     Text format     Abstract available


    May 2017
  351. MEZI S, Chiappetta C, Carletti R, Nardini A, et al
    Clinical significance of epithelial-to-mesenchymal transition in laryngeal carcinoma: its role in the different subsites.
    Head Neck. 2017 May 31. doi: 10.1002/hed.24838.
    PubMed     Text format     Abstract available


  352. MARUCCI L, Farneti A, Di Ridolfi P, Pinnaro P, et al
    Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer.
    Head Neck. 2017 May 31. doi: 10.1002/hed.24832.
    PubMed     Text format     Abstract available


  353. MIFSUD M, Eskander A, Irish J, Gullane P, et al
    Evolving trends in head and neck cancer epidemiology: Ontario, Canada 1993-2010.
    Head Neck. 2017 May 30. doi: 10.1002/hed.24829.
    PubMed     Text format     Abstract available


  354. HONDA K, Asato R, Tsuji J, Miyazaki M, et al
    Oncologic safety of cervical nerve preservation in neck dissection for head and neck cancer.
    Head Neck. 2017 May 30. doi: 10.1002/hed.24826.
    PubMed     Text format     Abstract available


  355. ZAIRIS S, Margalit DN, Royce TJ, Powlis WD, et al
    Prospective analysis of radiation oncology image and plan-driven peer review for head and neck cancer.
    Head Neck. 2017 May 17. doi: 10.1002/hed.24800.
    PubMed     Text format     Abstract available


  356. LEE JH, Hwang Y, Song RY, Yi JW, et al
    Relationship between iodine levels and papillary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2017 May 17. doi: 10.1002/hed.24797.
    PubMed     Text format     Abstract available


  357. SEKINE T, Barbosa FG, Delso G, Burger IA, et al
    Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT.
    Head Neck. 2017 May 13. doi: 10.1002/hed.24783.
    PubMed     Text format     Abstract available


  358. ERKAN S, Savundra JM, Wood B, Acharya AN, et al
    Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: Outcomes and prognostic implications of multimodality and salvage treatment.
    Head Neck. 2017 May 5. doi: 10.1002/hed.24607.
    PubMed     Text format     Abstract available


  359. WEISS BG, Ihler F, Wolff HA, Schneider S, et al
    Transoral laser microsurgery for treatment for hypopharyngeal cancer in 211 patients.
    Head Neck. 2017 May 5. doi: 10.1002/hed.24814.
    PubMed     Text format     Abstract available


  360. HINSON AM, Massoll NA, Jolly LA, Stack BC Jr, et al
    Structural alterations in tumor-draining lymph nodes before papillary thyroid carcinoma metastasis.
    Head Neck. 2017 May 3. doi: 10.1002/hed.24807.
    PubMed     Text format     Abstract available


  361. LIN CS, de Oliveira Santos AB, Silva EL, de Matos LL, et al
    Tumor volume as an independent predictive factor of worse survival in patients with oral cavity squamous cell carcinoma.
    Head Neck. 2017;39:960-964.
    PubMed     Text format     Abstract available


  362. SOSA A, Heineman N, Thomas K, Tang K, et al
    Improving patient health engagement with mobile texting: A pilot study in the head and neck postoperative setting.
    Head Neck. 2017;39:988-995.
    PubMed     Text format     Abstract available


  363. LIKHTEROV I, Reis LL, Urken ML
    Central compartment management in patients with papillary thyroid cancer presenting with metastatic disease to the lateral neck: Anatomic pathways of lymphatic spread.
    Head Neck. 2017;39:853-859.
    PubMed     Text format     Abstract available


  364. AMIT M, Na'ara S, Trejo-Leider L, Ramer N, et al
    Defining the surgical margins of adenoid cystic carcinoma and their impact on outcome: An international collaborative study.
    Head Neck. 2017;39:1008-1014.
    PubMed     Text format     Abstract available


  365. ZHANG D, Li F, Wu CW, Liu X, et al
    Percutaneous probe stimulation for intraoperative neuromonitoring in total endoscopic thyroidectomy: A preliminary experience.
    Head Neck. 2017;39:1001-1007.
    PubMed     Text format     Abstract available


  366. SOWDER JC, Cannon RB, Buchmann LO, Hunt JP, et al
    Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: A population-based study.
    Head Neck. 2017;39:876-880.
    PubMed     Text format     Abstract available


  367. BROCKHOFF HC 2ND, Kim RY, Braun TM, Skouteris C, et al
    Correlating the depth of invasion at specific anatomic locations with the risk for regional metastatic disease to lymph nodes in the neck for oral squamous cell carcinoma.
    Head Neck. 2017;39:974-979.
    PubMed     Text format     Abstract available


  368. BROWN TJ, Sher DJ, Nedzi LA, Hughes RS, et al
    Cutaneous adnexal adenocarcinoma with exquisite sensitivity to trastuzumab.
    Head Neck. 2017;39:E69-E71.
    PubMed     Text format     Abstract available


  369. LOPEZ F, Triantafyllou A, Snyderman CH, Hunt JL, et al
    Nasal juvenile angiofibroma: Current perspectives with emphasis on management.
    Head Neck. 2017;39:1033-1045.
    PubMed     Text format     Abstract available


  370. WELLER MA, Ward MC, Berriochoa C, Reddy CA, et al
    Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancer.
    Head Neck. 2017;39:940-946.
    PubMed     Text format     Abstract available


  371. MORISOD B, Venara-Vulpe II, Alzuphar S, Monnier Y, et al
    Minimizing adjuvant treatment after transoral robotic surgery through surgical margin revision and exclusion of radiographic extracapsular extension: A Prospective observational cohort study.
    Head Neck. 2017;39:965-973.
    PubMed     Text format     Abstract available


  372. KANG SY, Old MO, Teknos TN
    Lateral arm free tissue transfer for parotid reconstruction: A pictorial essay.
    Head Neck. 2017;39:1015-1019.
    PubMed     Text format     Abstract available


  373. CHOU WC, Chang KP, Lu CH, Chen MF, et al
    Complementary role of the Memorial Sloan Kettering Cancer Center nomogram to the American Joint Committee on Cancer system for the prediction of relapse of major salivary gland carcinoma after surgery.
    Head Neck. 2017;39:860-867.
    PubMed     Text format     Abstract available


  374. LANSAAT L, van den Boer C, Muller SH, van der Noort V, et al
    Ex vivo humidifying capacity and patient acceptability of stoma cloths in laryngectomized individuals.
    Head Neck. 2017;39:921-931.
    PubMed     Text format     Abstract available


    April 2017
  375. AGRAWAL N, Evasovich MR, Kandil E, Noureldine SI, et al
    Indications and extent of central neck dissection for papillary thyroid cancer: An American Head and Neck Society Consensus Statement.
    Head Neck. 2017 Apr 27. doi: 10.1002/hed.24715.
    PubMed     Text format     Abstract available


  376. CHANG PH, Yeh KY, Wang CH, Chen EY, et al
    Impact of metformin on patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
    Head Neck. 2017 Apr 27. doi: 10.1002/hed.24793.
    PubMed     Text format     Abstract available


  377. LIU SY, Feng IJ, Wu YW, Chen CY, et al
    Implication for second primary cancer from visible oral and oropharyngeal premalignant lesions in betel-nut chewing related oral cancer.
    Head Neck. 2017 Apr 6. doi: 10.1002/hed.24777.
    PubMed     Text format     Abstract available


  378. FUJIWARA RJ, Judson BL, Yarbrough WG, Husain Z, et al
    Treatment delays in oral cavity squamous cell carcinoma and association with survival.
    Head Neck. 2017;39:639-646.
    PubMed     Text format     Abstract available


  379. GARCIA-OLMO DC, Contreras JD, Picazo MG, Lopez-Torres J, et al
    Potential clinical significance of perioperative levels of mRNA in plasma from patients with cancer of the larynx or hypopharynx.
    Head Neck. 2017;39:647-655.
    PubMed     Text format     Abstract available


  380. VAN LOON Y, Stiggelbout AM, Hakkesteegt MM, Langeveld TP, et al
    Utility approach to decision-making in extended T1 and limited T2 glottic carcinoma.
    Head Neck. 2017;39:779-785.
    PubMed     Text format     Abstract available


  381. KIL WJ, Camphausen K
    Cyclical hypofractionated radiotherapy also known as "QUAD Shot" alone using intensity-modulated radiotherapy for squamous cell carcinoma of the parotid gland in an 85-year-old patient with multiple comorbidities.
    Head Neck. 2017;39:E55-E60.
    PubMed     Text format     Abstract available


  382. LEE JH, Chung YS, Lee YD
    A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study.
    Head Neck. 2017;39:767-771.
    PubMed     Text format     Abstract available


  383. DUEK I, Amit M, Sviri GE, Gil Z, et al
    Combined endoscopic transcervical-transoral robotic approach for resection of parapharyngeal space tumors.
    Head Neck. 2017;39:786-790.
    PubMed     Text format     Abstract available


  384. ZHOU L, Luo W
    Vascular endothelial growth factor-targeted paclitaxel-loaded liposome microbubbles and inhibition of human epidermoid-2 cell proliferation.
    Head Neck. 2017;39:656-661.
    PubMed     Text format     Abstract available


  385. OSORIO M, Moubayed SP, Su H, Urken ML, et al
    Systematic review of site distribution of bone metastases in differentiated thyroid cancer.
    Head Neck. 2017;39:812-818.
    PubMed     Text format     Abstract available


  386. TURRI-ZANONI M, Salzano G, Lambertoni A, Giovannardi M, et al
    Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.
    Head Neck. 2017;39:730-736.
    PubMed     Text format     Abstract available


  387. ALMADORI G, Lauriola L, Coli A, Bussu F, et al
    Minichromosome maintenance protein 7 and geminin expression: Prognostic value in laryngeal squamous cell carcinoma in patients treated with radiotherapy and cetuximab.
    Head Neck. 2017;39:684-693.
    PubMed     Text format     Abstract available


  388. FERNANDEZ-RIERA R, Hung SY, Wu JC, Tsao CK, et al
    Free profunda femoris artery perforator flap as a first-line choice of reconstruction for partial glossectomy defects.
    Head Neck. 2017;39:737-743.
    PubMed     Text format     Abstract available


  389. TURRI-ZANONI M, Battaglia P, Karligkiotis A, Lepera D, et al
    Transnasal endoscopic partial maxillectomy: Operative nuances and proposal for a comprehensive classification system based on 1378 cases.
    Head Neck. 2017;39:754-766.
    PubMed     Text format     Abstract available


  390. QUINLAN-DAVIDSON SR, Morrison WH, Myers JN, Gunn GB, et al
    Recurrent oral cavity cancer: Patterns of failure after salvage multimodality therapy.
    Head Neck. 2017;39:633-638.
    PubMed     Text format     Abstract available


  391. LUKSIC I, Suton P
    Predictive markers for delayed lymph node metastases and survival in early-stage oral squamous cell carcinoma.
    Head Neck. 2017;39:694-701.
    PubMed     Text format     Abstract available


  392. KOTO M, Hasegawa A, Takagi R, Ikawa H, et al
    Definitive carbon-ion radiotherapy for locally advanced parotid gland carcinomas.
    Head Neck. 2017;39:724-729.
    PubMed     Text format     Abstract available


  393. TESSEROLI MA, Zasso FB, Hepp H, Priante AV, et al
    Parotidectomy under sedation and locoregional anesthesia with monitoring of brain activity.
    Head Neck. 2017;39:744-747.
    PubMed     Text format     Abstract available


  394. JARROM D, Paleri V, Kerawala C, Roques T, et al
    Mucosal melanoma of the upper airways tract mucosal melanoma: A systematic review with meta-analyses of treatment.
    Head Neck. 2017;39:819-825.
    PubMed     Text format     Abstract available


  395. STUANI VT, Rubira CM, Sant'Ana AC, Santos PS, et al
    Salivary biomarkers as tools for oral squamous cell carcinoma diagnosis: A systematic review.
    Head Neck. 2017;39:797-811.
    PubMed     Text format     Abstract available


    March 2017
  396. TIGHE DF, Thomas AJ, Sassoon I, Kinsman R, et al
    Developing a risk stratification tool for audit of outcome after surgery for head and neck squamous cell carcinoma.
    Head Neck. 2017 Mar 29. doi: 10.1002/hed.24769.
    PubMed     Text format     Abstract available


  397. RIDDER M, Klop M, Hamming-Vrieze O, Boer J, et al
    Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.
    Head Neck. 2017 Mar 28. doi: 10.1002/hed.24762.
    PubMed     Text format     Abstract available


  398. REYES-GIBBY CC, Melkonian SC, Hanna EY, Yeung SJ, et al
    Cohort study of oncologic emergencies in patients with head and neck cancer.
    Head Neck. 2017 Mar 27. doi: 10.1002/hed.24748.
    PubMed     Text format     Abstract available


  399. WANG YY, Chen YK, Hsu YL, Chiu WC, et al
    Synthetic beta-nitrostyrene derivative CYT-Rx20 as inhibitor of oral cancer cell proliferation and tumor growth through glutathione suppression and reactive oxygen species induction.
    Head Neck. 2017 Mar 27. doi: 10.1002/hed.24664.
    PubMed     Text format     Abstract available


  400. GAMA RR, Song Y, Zhang Q, Brown MC, et al
    Body mass index and prognosis in patients with head and neck cancer.
    Head Neck. 2017 Mar 21. doi: 10.1002/hed.24760.
    PubMed     Text format     Abstract available


  401. WU WJ, Shao X, Huang MW, Lv XM, et al
    Postoperative iodine-125 interstitial brachytherapy for the early stages of minor salivary gland carcinomas of the lip and buccal mucosa with positive or close margins.
    Head Neck. 2017;39:572-577.
    PubMed     Text format     Abstract available


  402. GROSHEVA M, Shabli S, Volk GF, Sommer B, et al
    Sensation loss after superficial parotidectomy: A prospective controlled multicenter trial.
    Head Neck. 2017;39:520-526.
    PubMed     Text format     Abstract available


  403. CHONG LS, Eviston TJ, Ashford B, Ebrahami A, et al
    Single innervated segmented vastus lateralis for midfacial reanimation during radical parotidectomy.
    Head Neck. 2017;39:602-604.
    PubMed     Text format     Abstract available


  404. SIDDIQUI F, Smith RV, Yom SS, Beitler JJ, et al
    ACR appropriateness criteria((R)) nasal cavity and paranasal sinus cancers.
    Head Neck. 2017;39:407-418.
    PubMed     Text format     Abstract available


  405. BERGER MH, Kerr DA, Rangel Filho AE, Sargi ZB, et al
    Case of parotid mucoepidermoid carcinoma: Expanding the spectrum of von Hippel-Lindau-related neoplasms.
    Head Neck. 2017;39:E51-E54.
    PubMed     Text format     Abstract available


  406. THORPE LM, Schrock AB, Erlich RL, Miller VA, et al
    Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.
    Head Neck. 2017;39:E40-E44.
    PubMed     Text format     Abstract available


  407. BOEVE K, Schepman KP, Vegt BV, Schuuring E, et al
    Lymphatic drainage patterns of oral maxillary tumors: Approachable locations of sentinel lymph nodes mainly at the cervical neck level.
    Head Neck. 2017;39:486-491.
    PubMed     Text format     Abstract available


  408. MANTSOPOULOS K, Scherl C, Iro H
    Investigation of arguments against properly indicated extracapsular dissection in the parotid gland.
    Head Neck. 2017;39:498-502.
    PubMed     Text format     Abstract available


  409. IWAKI S, Maeda T, Saito M, Otsuki N, et al
    Role of immediate recurrent laryngeal nerve reconstruction in surgery for thyroid cancers with fixed vocal cords.
    Head Neck. 2017;39:427-431.
    PubMed     Text format     Abstract available


  410. NISHIO N, Fujii M, Hayashi Y, Hiramatsu M, et al
    Preoperative surgical simulation and validation of the line of resection in anterolateral craniofacial resection of advanced sinonasal sinus carcinoma.
    Head Neck. 2017;39:512-519.
    PubMed     Text format     Abstract available


  411. LING S, Bhatt AD, Brown NV, Nguyen P, et al
    Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation.
    Head Neck. 2017;39:548-554.
    PubMed     Text format     Abstract available


  412. GAO LL, Basta M, Kanchwala SK, Serletti JM, et al
    Cost-effectiveness of microsurgical reconstruction for head and neck defects after oncologic resection.
    Head Neck. 2017;39:541-547.
    PubMed     Text format     Abstract available


  413. HERNANDEZ-PRERA JC, Kwan R, Tripodi J, Chiosea S, et al
    Reappraising hyalinizing clear cell carcinoma: A population-based study with molecular confirmation.
    Head Neck. 2017;39:503-511.
    PubMed     Text format     Abstract available


  414. LOMBARDI D, Mattavelli D, Redaelli De Zinis LO, Accorona R, et al
    Primary Ewing's sarcoma of the sinonasal tract in adults: A challenging disease.
    Head Neck. 2017;39:E45-E50.
    PubMed     Text format     Abstract available


  415. SIVARS L, Landin D, Haeggblom L, Tertipis N, et al
    Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Head Neck. 2017;39:419-426.
    PubMed     Text format     Abstract available


  416. BURGESS M, Leung M, Chellapah A, Clark JR, et al
    Osseointegrated implants into a variety of composite free flaps: A comparative analysis.
    Head Neck. 2017;39:443-447.
    PubMed     Text format     Abstract available


  417. FAGAN JJ, Zafereo M, Aswani J, Netterville JL, et al
    Head and neck surgical subspecialty training in Africa: Sustainable models to improve cancer care in developing countries.
    Head Neck. 2017;39:605-611.
    PubMed     Text format     Abstract available


  418. MATTHEIS S, Hasskamp P, Holtmann L, Schafer C, et al
    Flex Robotic System in transoral robotic surgery: The first 40 patients.
    Head Neck. 2017;39:471-475.
    PubMed     Text format     Abstract available


  419. VAN WEERT S, Reinhard R, Bloemena E, Buter J, et al
    Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck.
    Head Neck. 2017;39:456-463.
    PubMed     Text format     Abstract available


  420. YU Y, Mabray M, Silveira W, Shen PY, et al
    Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Head Neck. 2017;39:432-438.
    PubMed     Text format     Abstract available


  421. JUNG JH, Lee SW, Son SH, Kim CY, et al
    Clinical impact of (18) F-FDG positron emission tomography/CT on adenoid cystic carcinoma of the head and neck.
    Head Neck. 2017;39:447-455.
    PubMed     Text format     Abstract available


    February 2017
  422. GOOI Z, Richmon J, Agrawal N, Blair E, et al
    AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines.
    Head Neck. 2017;39:201-205.
    PubMed     Text format     Abstract available


  423. KADLETZ L, Grasl S, Grasl MC, Perisanidis C, et al
    Extracapsular dissection versus superficial parotidectomy in benign parotid gland tumors: The Vienna Medical School experience.
    Head Neck. 2017;39:356-360.
    PubMed     Text format     Abstract available


  424. FRISCH T
    Versatility of the facial artery myomucosal island flap in neopharyngeal reconstruction.
    Head Neck. 2017;39:E29-E33.
    PubMed     Text format     Abstract available


  425. MCDOWELL LJ, Jacobson MC, Levin W
    High-dose intravenous steroid regimen for radiation-induced hypoglossal nerve palsy.
    Head Neck. 2017;39:E23-E28.
    PubMed     Text format     Abstract available


  426. MEHTA V, Flores JM, Thompson RW, Nathan CA, et al
    Primary payer status, individual patient characteristics, and hospital-level factors affecting length of stay and total cost of hospitalization in total laryngectomy.
    Head Neck. 2017;39:311-319.
    PubMed     Text format     Abstract available


  427. GAVRIEL H, Eviatar E, Abu Eta R
    Hyperbaric oxygen therapy for maxillary bone radiation-induced injury: A 15-year single-center experience.
    Head Neck. 2017;39:275-278.
    PubMed     Text format     Abstract available


  428. WEAVER AN, Cooper TS, Wei S, Carroll WR, et al
    DNA-PkCS expression in oropharyngeal squamous cell carcinoma: Correlations with human papillomavirus status and recurrence after transoral robotic surgery.
    Head Neck. 2017;39:206-214.
    PubMed     Text format     Abstract available


    January 2017
  429. CANNON RB, Sowder JC, Buchmann LO, Hunt JP, et al
    Increasing use of nonsurgical therapy in advanced-stage oral cavity cancer: A population-based study.
    Head Neck. 2017;39:82-91.
    PubMed     Text format     Abstract available


  430. HOFSTEDE TM, Jacob RF, Montgomery P, Wesley P, et al
    Surgical preparation of nasal defects to enhance the implant-retained facial prostheses: A case report.
    Head Neck. 2017;39:E4-E11.
    PubMed     Text format     Abstract available


  431. BOON E, van der Graaf WT, Gelderblom H, Tesselaar ME, et al
    Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults.
    Head Neck. 2017;39:140-146.
    PubMed     Text format     Abstract available


  432. KATZ O, Nachalon Y, Hilly O, Shpitzer T, et al
    Radiotherapy in early-stage tongue squamous cell carcinoma with minor adverse features.
    Head Neck. 2017;39:147-150.
    PubMed     Text format     Abstract available


  433. BEECH NM, Porceddu S, Batstone MD
    Radiotherapy-associated dental extractions and osteoradionecrosis.
    Head Neck. 2017;39:128-132.
    PubMed     Text format     Abstract available


  434. PRPIC M, Kust D, Kruljac I, Kirigin LS, et al
    Prediction of radioactive iodine remnant ablation failure in patients with differentiated thyroid cancer: A cohort study of 740 patients.
    Head Neck. 2017;39:109-115.
    PubMed     Text format     Abstract available


  435. ORBACH D, Mosseri V, Gallego S, Kelsey A, et al
    Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies.
    Head Neck. 2017;39:24-31.
    PubMed     Text format     Abstract available


  436. ANSARIN M, Cattaneo A, De Benedetto L, Zorzi S, et al
    Retrospective analysis of factors influencing oncologic outcome in 590 patients with early-intermediate glottic cancer treated by transoral laser microsurgery.
    Head Neck. 2017;39:71-81.
    PubMed     Text format     Abstract available


  437. KNOPF A, Bas M, Hofauer B, Mansour N, et al
    Clinicopathological characteristics of head and neck Merkel cell carcinomas.
    Head Neck. 2017;39:92-97.
    PubMed     Text format     Abstract available


  438. RACKLEY TP, Namelo WC, Palaniappan N, Cole N, et al
    Unilateral radiotherapy for surgically resected lateralized squamous cell carcinoma of the tonsil.
    Head Neck. 2017;39:17-23.
    PubMed     Text format     Abstract available


  439. MERMOD M, Bongiovanni M, Petrova TV, Dubikovskaya EA, et al
    Correlation between podoplanin expression and extracapsular spread in squamous cell carcinoma of the oral cavity using subjective immunoreactivity scores and semiquantitative image analysis.
    Head Neck. 2017;39:98-108.
    PubMed     Text format     Abstract available


  440. LAARA E, Korpi JT, Pitkanen H, Alho OP, et al
    Competing risks analysis of cause-specific mortality in patients with oral squamous cell carcinoma.
    Head Neck. 2017;39:56-62.
    PubMed     Text format     Abstract available


  441. BAUMEISTER P, Rauch J, Jacobi C, Kisser U, et al
    Impact of comorbidity and anemia in patients with oropharyngeal cancer primarily treated with surgery in the human papillomavirus era.
    Head Neck. 2017;39:7-16.
    PubMed     Text format     Abstract available


  442. STROM T, Naghavi AO, Messina JL, Kim S, et al
    Improved local and regional control with radiotherapy for Merkel cell carcinoma of the head and neck.
    Head Neck. 2017;39:48-55.
    PubMed     Text format     Abstract available


  443. RAGUIN T, Schneegans O, Rodier JF, Volkmar PP, et al
    Value of fine-needle aspiration in evaluating large thyroid nodules.
    Head Neck. 2017;39:32-36.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: